Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdTCR [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"
ALPI		ENSG00000163295	"Alkaline phosphatase, intestinal"	P09923	2	232456123-232460032	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	406	"intestine: 133.2"	"Cell line enriched"	"Detected in some"	12	"CACO-2: 12.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 4.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA038764, HPA038765, HPA051699"	Supported		Approved	"Plasma membrane"	"Intracellular and membrane"			"Plasma membrane"	"Plasma membrane"	"HPA038764: AB_2676194, HPA038765: AB_2676195, HPA051699: AB_2681577"			"unprognostic (1.01e-1)"	"unprognostic (7.71e-2)"			"unprognostic (4.14e-2)"			"unprognostic (1.47e-1)"	"unprognostic (9.57e-4)"		"unprognostic (8.07e-2)"	"unprognostic (1.71e-1)"	"unprognostic (9.99e-2)"			0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1	63.0	0.0	0.0	57.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	1.3	0.0	0.1	0.0	0.1	0.1	133.2	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	12.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.2	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
C17orf78	FLJ39647	ENSG00000278505	"Chromosome 17 open reading frame 78"	Q8N4C9	17	37375986-37392708	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	401	"intestine: 83.8"	"Cell line enhanced"	"Detected in some"		"BEWO: 1.5;NB-4: 1.6;RPMI-8226: 1.4"	"Group enriched"	"Detected in some"	8	"colorectal cancer: 0.8;stomach cancer: 1.3"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"														"unprognostic (8.73e-3)"	"unprognostic (1.91e-1)"	"unprognostic (8.98e-2)"	"unprognostic (4.90e-3)"	"unprognostic (5.31e-2)"	"unprognostic (7.83e-2)"	"unprognostic (2.59e-2)"	"unprognostic (2.02e-1)"	"unprognostic (7.62e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.43e-1)"	"unprognostic (5.53e-6)"	"unprognostic (1.94e-2)"	"unprognostic (7.23e-3)"	"unprognostic (4.85e-2)"	"unprognostic (3.19e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.4	0.0	0.0	44.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	83.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.4	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.4	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.7	0.0	0.2	0.0	1.6	0.2	0.3	0.2	0.1	1.4	0.1	0.0	0.9	0.7	0.2	0.0	0.2	0.3	0.0	0.3	0.1	0.1	0.8	0.2	0.3	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
MUC17		ENSG00000169876	"Mucin 17, cell surface associated"	Q685J3	7	101020072-101058745	"Cancer-related genes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	299	"intestine: 125.2"	"Cell line enhanced"	"Detected in single"		"BEWO: 1.3"	"Group enriched"	"Detected in some"	29	"colorectal cancer: 6.1;pancreatic cancer: 4.9;stomach cancer: 22.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA031634	Enhanced				"Intracellular and membrane"					"HPA031634: AB_10603021"			"unprognostic (2.37e-2)"	"unprognostic (2.41e-1)"		"unprognostic (8.17e-3)"					"unprognostic (5.57e-3)"	"unprognostic (6.07e-2)"	"unprognostic (8.79e-8)"	"unprognostic (1.28e-1)"	"unprognostic (2.47e-2)"			0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	64.7	0.0	0.0	15.8	0.0	0.0	0.1	0.0	0.4	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	2.5	0.0	0.1	0.0	0.1	0.1	125.2	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0
DEFA5	"DEF5, HD-5"	ENSG00000164816	"Defensin alpha 5"	Q01523	8	7055304-7056734	"Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	231	"intestine: 574.2"	"Group enriched"	"Detected in some"	8	"BEWO: 19.5;NB-4: 16.0;RPMI-8226: 16.8;SH-SY5Y: 13.7;U-2197: 5.9"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 181.1;colorectal cancer: 147.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA015309, HPA015775, CAB069919"	Enhanced		Approved	Vesicles,Midbody	"Secreted to digestive system"			Vesicles	Vesicles	"CAB069919: AB_905358, HPA015309: , HPA015775: AB_1847594"			"prognostic favourable (9.44e-5)"											"unprognostic (3.91e-2)"				0.1	0.1	0.1	0.3	0.1	0.0	0.1	0.1	0.1	0.1	408.9	0.0	0.0	249.9	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.1	0.1	574.2	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.2	0.0	0.1	0.1	0.0	0.0	0.7	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	19.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.0	0.0	0.0	0.0	0.0	16.8	0.0	0.0	1.7	13.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	2.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
RBP2	"CRABP-II, CRBP2, CRBPII, RBPC2"	ENSG00000114113	"Retinol binding protein 2"	P50120	3	139452884-139480747	"Predicted intracellular proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	198	"intestine: 333.2"	"Cell line enriched"	"Detected in some"	7	"CACO-2: 40.9"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 8.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	4	"basal ganglia: 4.6"	"Not detected"	"Not detected"			HPA035866	Enhanced		Approved	"Golgi apparatus"		96000	96000	"Golgi apparatus"	"Golgi apparatus"	"HPA035866: AB_10672232"	"unprognostic (1.74e-1)"	"unprognostic (2.66e-2)"	"unprognostic (3.34e-2)"	"unprognostic (6.72e-6)"	"unprognostic (2.33e-1)"	"unprognostic (4.10e-2)"	"unprognostic (1.56e-2)"	"unprognostic (2.24e-1)"	"unprognostic (8.51e-3)"	"unprognostic (3.92e-2)"	"unprognostic (7.35e-2)"	"unprognostic (1.24e-3)"	"unprognostic (5.57e-3)"	"unprognostic (1.10e-1)"	"unprognostic (9.23e-2)"	"unprognostic (1.78e-2)"	"unprognostic (2.21e-1)"	0.1	0.2	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.2	130.1	0.0	0.0	221.8	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.4	0.1	1.6	0.0	0.1	0.0	0.1	0.4	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.1	0.1	333.2	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.0	0.9	0.0	0.0	0.1	0.1	0.1	0.0	0.0	3.8	0.0	0.0	0.0	0.0	40.9	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	3.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	2.1	5.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0
DEFA6	"DEF6, HD-6"	ENSG00000164822	"Defensin alpha 6"	Q01524	8	6924693-6926076	"Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	189	"intestine: 316.3"	"Group enriched"	"Detected in some"	12	"BEWO: 12.5;NB-4: 13.1;RPMI-8226: 15.4;SH-SY5Y: 10.6;U-2197: 4.9"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 75.8"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"memory B-cell: 1.6"	"Lineage enriched"	"Detected in single"	17	"B-cells: 1.6"									HPA019462	Enhanced				"Secreted to digestive system"					"HPA019462: AB_1847595"			"unprognostic (7.48e-3)"											"unprognostic (1.63e-1)"	"unprognostic (1.34e-1)"			0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	262.3	0.0	0.0	181.7	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	316.3	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.0	0.1	0.1	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.1	0.0	0.0	0.0	0.0	15.4	0.0	0.0	0.9	10.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
MLN		ENSG00000096395	Motilin	P12872	6	33794673-33804011	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in single"	175	"intestine: 76.0"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 1.6;BEWO: 1.8;CACO-2: 7.4;RPMI-8226: 1.7;TIME: 3.4"	"Cancer enriched"	"Detected in some"	6	"testis cancer: 5.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA069392	Enhanced				"Secreted to blood"					"HPA069392: AB_2686136"					"unprognostic (7.70e-2)"					"unprognostic (6.70e-2)"				"unprognostic (4.44e-2)"	"unprognostic (3.14e-1)"			0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	58.4	0.0	0.0	76.0	0.1	0.0	0.3	0.1	0.2	0.1	0.1	0.2	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	30.6	0.0	0.2	0.1	0.1	0.2	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.6	0.0	0.0	1.8	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	1.0	1.2	0.0	0.0	0.0	1.7	0.0	0.0	0.6	0.8	0.0	0.0	0.0	0.0	0.0	3.4	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.0	0.0	0.0
MEP1B		ENSG00000141434	"Meprin A subunit beta"	Q16820	18	32185069-32220404	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	167	"intestine: 241.5"	"Cell line enhanced"	"Detected in some"		"SCLC-21H: 10.3"	"Group enriched"	"Detected in some"	5	"pancreatic cancer: 3.0;stomach cancer: 0.6"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA029119	Enhanced				"Secreted to digestive system"	120000	120000			"HPA029119: AB_2672913"	"unprognostic (1.33e-1)"	"unprognostic (6.72e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.50e-4)"	"unprognostic (1.27e-1)"	"unprognostic (1.74e-2)"	"unprognostic (4.30e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.55e-1)"	"unprognostic (8.31e-4)"	"unprognostic (4.74e-2)"	"unprognostic (3.39e-1)"	"unprognostic (2.71e-1)"	"unprognostic (3.39e-2)"	"unprognostic (3.75e-2)"	0.1	0.1	0.1	0.4	0.1	0.0	0.1	0.3	0.1	0.1	78.8	0.0	0.0	54.5	0.1	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	1.2	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.1	0.1	241.5	0.0	0.1	0.1	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.1	1.1	0.4	0.3	0.3	0.0	1.4	0.5	0.2	0.0	0.0	0.5	0.6	0.0	2.0	1.0	0.3	0.2	0.1	0.5	1.4	1.7	0.5	0.0	0.2	0.0	0.0	0.0	0.7	0.9	1.1	0.7	0.6	0.4	1.3	0.3	0.0	0.7	0.0	0.1	0.4	1.1	0.2	0.0	1.9	1.3	4.0	1.3	0.0	1.8	1.7	2.9	0.0	0.7	10.3	2.3	0.8	0.2	0.3	0.4	3.0	0.9	1.3	0.8	3.4	0.0	0.5	2.2	0.5	2.6	0.0	0.5	0.0	0.3	0.3	1.0	0.1	1.3	1.1	0.7	1.4	0.4	0.1	1.2	0.3	0.2	0.0	0.1	0.2	0.5	0.5	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.0	0.0	0.0
LCT		ENSG00000115850	Lactase	P09848	2	135787840-135837180	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	133	"intestine: 255.5"	"Group enriched"	"Detected in some"	5	"MOLT-4: 6.8;RPMI-8226: 13.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	19	"plasmacytoid DC: 1.9"	"Lineage enriched"	"Detected in single"	19	"dendritic cells: 1.9"	"Region enriched"	"Detected in single"	16	"hippocampal formation: 17.3"																"unprognostic (2.21e-2)"	"unprognostic (1.65e-4)"	"unprognostic (2.54e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.39e-2)"	"unprognostic (8.03e-4)"	"unprognostic (3.55e-3)"	"unprognostic (6.71e-3)"	"unprognostic (1.89e-1)"	"unprognostic (3.57e-1)"	"unprognostic (1.69e-1)"	"unprognostic (9.32e-2)"	"unprognostic (1.64e-4)"	"unprognostic (4.90e-2)"	"unprognostic (8.92e-2)"	"unprognostic (8.97e-2)"	"unprognostic (1.02e-1)"	0.1	0.1	0.2	0.0	0.1	0.0	0.1	0.2	0.1	0.1	209.8	0.0	0.0	67.7	0.1	0.0	0.1	0.1	0.0	0.1	0.3	0.2	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	255.5	0.0	0.1	0.1	0.1	0.4	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.9	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	6.8	1.1	0.0	0.0	1.6	0.0	13.6	0.0	0.0	0.6	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.2	0.1	0.2	0.1	0.3	0.2	0.1	0.0	0.0	0.0
SI		ENSG00000090402	Sucrase-isomaltase	P14410	3	164978898-165078495	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	123	"intestine: 181.4"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.8;CACO-2: 4.0;HeLa: 3.1;NB-4: 3.3;RPMI-8226: 4.8;SH-SY5Y: 2.9"	"Cancer enhanced"	"Detected in some"		"stomach cancer: 6.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA011897	Enhanced									"HPA011897: AB_1856840"			"unprognostic (2.71e-2)"								"unprognostic (1.62e-2)"	"unprognostic (2.68e-1)"		"unprognostic (2.05e-1)"	"unprognostic (4.41e-2)"			0.1	0.1	0.1	1.4	0.1	0.0	0.1	0.1	0.1	0.1	93.3	0.0	0.0	94.1	0.1	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	5.4	0.0	0.1	0.0	0.1	0.1	181.4	0.0	0.1	0.1	0.1	0.7	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.6	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
TM4SF20	"FLJ22800, TCCE518"	ENSG00000168955	"Transmembrane 4 L six family member 20"	Q53R12	2	227362156-227381995	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	86	"intestine: 147.8"	"Cell line enhanced"	"Detected in some"		"A549: 7.1;RPMI-8226: 4.4"	"Group enriched"	"Detected in many"	6	"colorectal cancer: 5.0;liver cancer: 4.7;pancreatic cancer: 5.5;stomach cancer: 11.8"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA051838, HPA063184, HPA065531"	Uncertain		Supported	"Plasma membrane,Focal adhesion sites"				"Plasma membrane, Focal adhesion sites"	"Plasma membrane, Focal adhesion sites"	"HPA051838: AB_2681631, HPA063184: AB_2684958, HPA065531: AB_2685506"	"unprognostic (4.68e-2)"	"unprognostic (1.13e-1)"	"unprognostic (8.75e-2)"		"unprognostic (4.96e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.51e-1)"	"unprognostic (2.36e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.44e-3)"	"unprognostic (7.76e-2)"	"unprognostic (2.60e-2)"	"unprognostic (3.04e-3)"		0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.1	46.5	0.0	0.0	73.5	0.1	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.9	0.0	0.1	0.0	0.1	0.1	147.8	0.2	0.1	0.1	0.1	1.2	0.0	0.0	0.1	0.0	0.0	0.1	0.1	1.1	1.2	1.1	0.5	1.7	0.7	0.0	0.1	7.1	0.2	0.1	0.0	0.0	1.3	0.8	0.1	0.0	0.0	1.3	0.5	0.2	0.1	0.4	0.2	0.0	0.0	0.1	0.1	0.4	0.0	1.3	0.2	0.0	0.5	0.3	0.0	0.1	0.0	0.0	0.0	0.4	0.8	0.3	0.0	0.1	1.6	0.3	0.1	0.4	0.1	4.4	0.1	0.3	0.6	1.7	1.0	0.1	0.0	0.3	0.1	0.3	0.6	0.3	1.9	0.2	0.5	0.3	0.4	0.2	0.2	0.2	0.8	0.5	0.1	0.7	0.3	0.3	0.7	0.4	0.4	0.0	1.1	0.7	0.5	1.1	1.7	0.1	1.2	0.4	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.0	0.0
FABP6	"I-15P, I-BABP, I-BALB, I-BAP, ILBP, ILBP3, ILLBP"	ENSG00000170231	"Fatty acid binding protein 6"	P51161	5	160187367-160238735	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	68	"intestine: 299.2"	"Cell line enhanced"	"Detected in some"		"Daudi: 20.2;EFO-21: 19.4;HDLM-2: 8.5;NB-4: 7.9;RPMI-8226: 9.3;RT4: 8.9;U-2197: 8.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in single"	8	"neutrophil: 1.0"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 1.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA012601, CAB024713"	Enhanced				"Intracellular and membrane"	650000	650000			"CAB024713: , HPA012601: AB_1848435"	"unprognostic (3.03e-2)"	"unprognostic (7.55e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.00e-3)"	"unprognostic (1.48e-2)"	"unprognostic (3.53e-1)"	"unprognostic (5.35e-7)"	"unprognostic (3.05e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.41e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.56e-1)"	"prognostic unfavourable (4.35e-9)"	"unprognostic (2.10e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.85e-3)"	0.1	0.9	0.2	0.1	0.4	0.0	0.1	0.1	0.1	0.5	0.1	0.3	0.1	0.2	0.3	0.1	0.1	4.3	0.1	0.1	0.4	0.5	0.1	0.1	1.3	0.1	0.4	0.1	0.5	0.1	0.0	0.2	0.1	1.0	0.1	0.0	0.1	0.4	0.1	0.1	0.0	299.2	0.1	0.2	0.1	0.0	0.1	0.2	1.2	0.1	0.5	0.2	0.2	0.1	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.0	6.3	0.0	0.0	0.0	0.0	3.4	0.6	20.2	19.4	0.0	0.0	0.0	0.0	0.0	8.5	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.2	0.0	0.8	0.2	0.0	0.0	0.0	7.9	0.0	1.8	0.0	0.6	9.3	0.0	8.9	1.7	0.4	0.0	5.1	0.1	0.0	0.1	0.0	0.0	0.0	8.4	1.0	1.1	4.4	2.2	0.2	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.1	0.1	0.4	0.5	0.4	0.1	1.0	0.2
TMPRSS15	"ENTK, MGC133046, PRSS7"	ENSG00000154646	"Transmembrane serine protease 15"	P98073	21	18269116-18485879	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	67	"intestine: 154.6"	"Group enriched"	"Detected in some"	20	"U-138 MG: 19.8;U-87 MG: 55.3"	"Group enriched"	"Detected in some"	12	"liver cancer: 0.7;pancreatic cancer: 1.5;stomach cancer: 1.5"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive B-cell: 2.3"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	5	"olfactory region: 9.3"	"HPA015611, HPA034857, HPA072934"	Enhanced		Approved	"Nucleoli,Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA015611: AB_1855791, HPA034857: , HPA072934: AB_2732214"					"unprognostic (9.26e-2)"	"unprognostic (4.14e-1)"		"unprognostic (3.52e-1)"	"unprognostic (8.33e-2)"	"unprognostic (1.19e-1)"	"unprognostic (7.20e-2)"	"unprognostic (4.70e-2)"		"unprognostic (6.35e-2)"	"unprognostic (5.92e-2)"			0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	80.5	0.0	0.0	154.6	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	42.4	0.0	0.1	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.3	0.0	0.5	0.1	0.6	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	1.9	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	1.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	19.8	0.0	0.1	0.0	0.3	0.0	0.0	55.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.3	0.1	0.5	0.6	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0
GIP		ENSG00000159224	"Gastric inhibitory polypeptide"	P09681	17	48958554-48968596	"Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	64	"intestine: 87.5"	"Group enriched"	"Detected in some"	4	"A549: 8.6;BEWO: 7.8;Hep G2: 12.3"	"Cancer enriched"	"Detected in some"	63	"testis cancer: 74.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB016729, HPA021612"	Enhanced				"Secreted to blood"					"CAB016729: , HPA021612: AB_1849506"										"unprognostic (2.95e-1)"	"unprognostic (2.70e-3)"			"unprognostic (4.42e-2)"	"unprognostic (1.82e-1)"			0.2	0.3	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	87.5	0.0	0.0	75.4	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	61.7	0.0	0.1	0.1	0.2	1.3	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.1	0.0	0.4	0.7	7.8	0.3	0.0	0.1	0.0	2.2	0.9	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	1.2	0.0	1.5	12.3	0.1	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	2.1	0.0	0.0	0.8	0.1	0.0	0.0	0.1	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.4	0.1	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
CEACAM18		ENSG00000213822	"Carcinoembryonic antigen related cell adhesion molecule 18"	A8MTB9	19	51478622-51490952	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	62	"intestine: 31.3"	"Group enriched"	"Detected in some"	13	"CACO-2: 9.4;RT4: 3.1"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 0.8;stomach cancer: 0.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA059487	Uncertain		Approved	Midbody				Midbody	Midbody	"HPA059487: AB_2684036"			"unprognostic (1.12e-1)"								"unprognostic (1.87e-2)"			"unprognostic (1.00e-1)"				0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	16.6	0.0	0.0	14.6	0.1	0.0	0.1	0.1	0.5	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	31.3	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	9.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
MEP1A	PPHA	ENSG00000112818	"Meprin A subunit alpha"	Q16819	6	46793390-46839782	"Enzymes, Plasma proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	52	"intestine: 243.0"	"Cell line enhanced"	"Detected in some"		"BEWO: 3.0;CACO-2: 6.9;Hep G2: 1.8;NB-4: 3.0;RPMI-8226: 3.4;SH-SY5Y: 2.1;U-2197: 2.0"	"Cancer enriched"	"Detected in many"	5	"colorectal cancer: 38.6"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"myeloid DC: 1.6"	"Lineage enriched"	"Detected in single"	8	"dendritic cells: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB025163, HPA029416"	Enhanced					990000	990000			"CAB025163: , HPA029416: AB_10600823"	"unprognostic (1.83e-1)"	"unprognostic (2.81e-4)"	"unprognostic (2.03e-1)"	"unprognostic (8.53e-2)"	"unprognostic (8.73e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.43e-2)"	"unprognostic (5.27e-4)"	"unprognostic (2.05e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.11e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.91e-2)"	"unprognostic (4.70e-3)"	"unprognostic (1.68e-1)"	0.1	0.1	0.1	4.7	0.1	0.0	0.1	0.1	0.1	0.1	100.5	0.1	0.1	51.7	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.5	0.0	0.1	0.1	0.1	0.1	19.8	0.1	0.2	0.1	0.1	0.1	243.0	0.2	0.2	0.2	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	1.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.4	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1
APOBEC1	"APOBEC-1, BEDP, CDAR1, HEPR"	ENSG00000111701	"Apolipoprotein B mRNA editing enzyme catalytic subunit 1"	P41238	12	7649400-7665903	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	51	"intestine: 56.1"	"Cell line enriched"	"Detected in single"	20	"CAPAN-2: 7.7"	"Group enriched"	"Detected in some"	9	"colorectal cancer: 6.2;pancreatic cancer: 6.1;stomach cancer: 3.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"																"unprognostic (2.35e-1)"					"unprognostic (3.80e-4)"			"unprognostic (7.96e-3)"			"unprognostic (1.79e-1)"	"unprognostic (4.38e-1)"			0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	16.8	0.0	0.0	23.7	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	56.1	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FABP2	I-FABP	ENSG00000145384	"Fatty acid binding protein 2"	P12104	4	119317250-119322390	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	47	"intestine: 358.6"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.8;Hep G2: 2.4;NB-4: 3.8;RPMI-8226: 3.2;SH-SY5Y: 2.6"	"Group enriched"	"Detected in some"	9	"colorectal cancer: 3.2;pancreatic cancer: 1.6;stomach cancer: 2.7"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"basophil: 2.1;neutrophil: 7.6"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 7.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA034607, CAB047325, CAB047326"	Enhanced		Approved	"Plasma membrane,Actin filaments,Cytosol"		46000	46000	"Actin filaments, Cytosol"	"Actin filaments, Cytosol"	"CAB047325: , CAB047326: , HPA034607: AB_10601317"		"unprognostic (3.94e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.05e-1)"				"unprognostic (4.58e-1)"		"unprognostic (1.51e-2)"	"unprognostic (2.61e-2)"		"unprognostic (1.69e-4)"	"unprognostic (1.93e-1)"	"unprognostic (1.02e-1)"			0.1	0.2	0.1	0.8	0.1	0.0	0.1	0.1	0.1	0.1	47.0	0.0	0.0	50.0	0.1	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	5.9	0.1	0.1	0.0	0.1	0.1	358.6	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.5	0.5	7.6	0.7	0.9	0.5	0.0	0.2	0.3	0.2	0.4	0.0	0.0	2.8	0.4	0.0	0.0	0.0	0.4	0.3	0.4	0.1	0.0	0.3	0.0	0.2	0.1	0.1	0.3	0.1	0.4	2.4	0.0	0.5	0.4	0.2	0.0	0.2	0.1	0.0	0.2	0.5	0.0	0.1	0.4	3.8	0.2	0.5	0.3	0.2	3.2	0.0	0.5	1.0	2.6	0.1	0.4	0.0	0.3	0.1	0.9	0.4	0.4	1.4	0.1	0.7	0.2	0.6	0.3	0.2	0.1	2.1	0.7	0.7	0.4	0.3	0.4	0.2	0.4	0.3	0.2	0.5	0.5	0.5	7.6	0.9	0.2	0.5	0.5	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
S100G	"CABP1, CABP9K, CALB3"	ENSG00000169906	"S100 calcium binding protein G"	P29377	X	16650158-16654670	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	44	"intestine: 74.2"	"Cell line enhanced"	"Detected in some"		"EFO-21: 1.0;PC-3: 2.2;RPMI-8226: 6.8;SH-SY5Y: 1.2"	"Group enriched"	"Detected in some"	5	"breast cancer: 4.7;renal cancer: 0.9"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive CD8 T-cell: 1.5"	"Lineage enriched"	"Detected in single"	5	"T-cells: 1.5"	"Region enriched"	"Detected in single"	5	"pons and medulla: 1.2"	"Low region specificity"	"Detected in all"			"CAB017688, HPA055873"	Enhanced									"CAB017688: AB_1119899, HPA055873: AB_2682952"	"unprognostic (2.68e-2)"									"unprognostic (2.78e-1)"				"unprognostic (9.88e-3)"				0.0	0.3	0.0	0.0	0.0	0.0	1.6	0.1	0.0	0.2	18.0	0.0	0.0	74.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	9.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.3	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	2.2	0.0	0.0	6.8	0.0	0.0	0.5	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.0	0.4	0.0	0.3	0.0	0.0	1.5	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GUCA2A	"GUCA2, STARA"	ENSG00000197273	"Guanylate cyclase activator 2A"	Q02747	1	42162691-42164718	"Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	33	"intestine: 265.7"	"Cell line enhanced"	"Detected in some"		"BEWO: 14.5;CACO-2: 11.3;NB-4: 3.7;U-2197: 3.2"	"Group enriched"	"Detected in many"	7	"colorectal cancer: 31.6;urothelial cancer: 8.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	4	"amygdala: 0.2"	HPA018215	Enhanced				"Secreted to blood"	26000000	26000000			"HPA018215: AB_1850443"			"unprognostic (7.98e-3)"		"unprognostic (1.60e-1)"		"unprognostic (1.16e-1)"	"unprognostic (9.07e-2)"			"unprognostic (1.14e-1)"			"unprognostic (8.06e-2)"	"unprognostic (2.89e-1)"	"unprognostic (3.10e-1)"	"unprognostic (9.15e-2)"	0.2	0.1	0.2	8.0	0.2	0.0	0.2	0.2	0.2	0.2	87.3	0.2	0.2	6.6	0.2	0.2	0.2	0.2	0.3	0.2	0.2	0.1	0.2	0.2	0.3	0.2	0.2	0.2	0.2	0.7	0.0	0.2	3.5	0.2	0.2	91.9	0.2	0.2	0.2	0.2	0.1	265.7	2.1	0.2	0.2	0.1	0.2	0.2	0.3	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.5	0.0	0.0	0.0	0.0	11.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2
MS4A10	"CD20L7, MS4A9"	ENSG00000172689	"Membrane spanning 4-domains A10"	Q96PG2	11	60785348-60801305	"Predicted membrane proteins, Transporters"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	33	"intestine: 115.7"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.3;NB-4: 2.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"basophil: 3.5"	"Low lineage specificity"	"Detected in single"							"Low region specificity"	"Detected in all"			HPA014778	Uncertain									"HPA014778: AB_2669089"					"unprognostic (7.67e-3)"						"unprognostic (1.28e-1)"	"unprognostic (8.73e-3)"		"unprognostic (1.27e-1)"	"unprognostic (5.21e-2)"			0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	28.3	0.0	0.0	33.4	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	115.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.7	3.5	0.5	0.9	0.5	0.1	0.3	0.9	0.4	0.2	0.2	0.0	2.3	0.2	0.1	0.1	0.0	0.8	0.2	0.4	0.3	0.1	0.7	0.2	0.3	0.2	0.0	0.3	2.1	0.7	0.3	0.1	0.5	1.8	0.0	0.0	0.5	0.3	0.0	0.5	1.4	0.7	0.3	0.5	2.4	0.0	0.3	0.2	0.0	1.7	0.1	0.4	1.0	0.9	0.4	0.6	0.0	0.4	0.2	1.4	0.7	0.2	1.4	0.3	0.2	0.2	0.4	0.4	0.7	0.2	3.5	0.4	0.7	0.5	0.3	0.4	0.5	0.3	0.3	0.2	0.8	0.5	0.5	1.4	0.9	0.5	0.7	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TMIGD1	"TMIGD, UNQ9372"	ENSG00000182271	"Transmembrane and immunoglobulin domain containing 1"	Q6UXZ0	17	30316333-30334059	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	33	"intestine: 47.3"	"Cell line enhanced"	"Detected in some"		"BEWO: 1.4;NB-4: 1.3;U-2197: 1.8;U-698: 1.9"	"Cancer enhanced"	"Detected in single"		"colorectal cancer: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA021946			Approved	Mitochondria				Mitochondria	Mitochondria	"HPA021946: "			"unprognostic (1.28e-1)"										"unprognostic (1.30e-1)"	"unprognostic (1.61e-1)"				0.2	0.0	0.2	1.1	0.2	0.0	0.2	0.2	0.2	0.2	26.8	0.2	0.2	0.0	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.0	1.4	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	33.9	0.2	0.2	0.2	0.2	0.0	47.3	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.8	0.1	0.0	0.0	1.9	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2
TMEM253	"C14orf176, C14orf95, NCRNA00220"	ENSG00000232070	"Transmembrane protein 253"	P0C7T8	14	21098937-21103724	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	31	"intestine: 110.5"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	7	"neutrophil: 1.6"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 1.6"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA052329, HPA065092"	Enhanced									"HPA052329: AB_2681791, HPA065092: AB_2685420"	"unprognostic (7.48e-3)"	"unprognostic (1.33e-2)"	"unprognostic (7.19e-2)"	"unprognostic (3.84e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.50e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.90e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.28e-2)"	"unprognostic (5.46e-2)"	"unprognostic (9.93e-2)"	"unprognostic (3.59e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.20e-2)"	"unprognostic (1.04e-1)"	0.4	1.5	0.4	2.2	0.4	0.0	0.3	0.5	0.5	0.5	32.6	0.4	2.0	41.8	0.4	0.8	0.9	0.2	3.1	0.9	0.3	0.4	0.4	0.5	0.4	0.2	0.5	0.4	0.4	0.7	0.4	0.3	0.5	0.4	0.5	5.7	0.4	2.8	0.7	0.3	0.6	110.5	0.6	0.3	0.4	0.2	0.4	0.2	0.2	3.6	0.8	0.7	0.3	0.5	0.0	0.2	1.6	0.0	0.0	0.0	0.0	0.4	0.9	2.7	2.6	4.0	1.0	4.4	1.0	2.0	0.5	0.9	2.3	2.1	3.2	0.6	0.2	4.2	0.9	5.0	0.6	1.9	0.2	1.6	3.0	2.7	0.6	0.0	0.1	1.9	4.3	2.1	3.4	0.3	1.1	0.2	1.3	0.9	0.1	0.3	3.5	0.1	0.7	1.3	1.8	2.3	2.0	0.7	1.4	1.1	0.8	2.4	0.8	0.0	0.0	0.0	1.5	0.5	0.3	0.8	0.4	0.0	0.2	1.3	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.2	0.0	0.0	0.4	0.4	0.5	0.5	0.3	0.4	0.5	0.4	0.4	0.2
ITLN2	HL-2	ENSG00000158764	"Intelectin 2"	Q8WWU7	1	160945025-160954799	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	29	"intestine: 88.4"	"Cell line enhanced"	"Detected in some"		"HEL: 15.3;HHSteC: 2.6;HMC-1: 4.6;SK-MEL-30: 4.9"	"Cancer enhanced"	"Detected in many"		"testis cancer: 4.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA006683, HPA067326"	Enhanced				"Secreted to digestive system"					"HPA006683: AB_2129681, HPA067326: AB_2732764"		"unprognostic (1.42e-1)"	"unprognostic (9.62e-3)"	"unprognostic (4.61e-2)"	"unprognostic (7.45e-2)"	"unprognostic (2.25e-1)"	"unprognostic (6.84e-4)"	"unprognostic (2.47e-2)"	"unprognostic (5.74e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.36e-1)"	"unprognostic (5.01e-1)"		"unprognostic (1.84e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.31e-1)"	"unprognostic (4.91e-2)"	3.0	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	27.4	0.1	0.1	53.3	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.0	0.1	0.1	2.5	0.1	0.1	0.1	0.6	0.1	0.0	0.1	0.1	0.1	0.2	0.0	0.1	0.1	0.1	0.1	0.1	88.4	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	15.3	0.0	0.0	2.6	0.0	4.6	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	1.5	0.0	0.0	0.0	1.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
SLC5A4	"DJ90G24.4, SAAT1, SGLT3"	ENSG00000100191	"Solute carrier family 5 member 4"	Q9NY91	22	32218476-32255341	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	29	"intestine: 73.6"	"Cell line enriched"	"Detected in some"	19	"SK-MEL-30: 24.6"	"Cancer enriched"	"Detected in some"	10	"melanoma: 7.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"														"unprognostic (1.93e-1)"	"unprognostic (1.57e-1)"	"unprognostic (3.10e-3)"	"unprognostic (1.63e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.85e-3)"	"unprognostic (2.97e-2)"	"unprognostic (3.80e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.65e-3)"	"unprognostic (4.50e-1)"	"unprognostic (1.99e-5)"	"unprognostic (2.34e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.69e-1)"	1.2	0.1	0.4	0.4	0.4	0.1	1.6	0.4	0.5	1.2	41.7	0.4	0.4	18.0	1.8	0.4	0.4	1.2	0.6	0.9	0.5	0.6	1.0	0.4	2.5	0.4	0.6	0.4	0.4	0.6	0.4	0.4	0.4	0.4	0.9	0.1	0.4	0.4	0.4	0.4	0.3	73.6	1.5	0.6	0.6	0.2	0.7	0.4	0.4	2.4	0.4	0.4	0.4	1.3	0.0	0.3	0.0	0.6	0.0	0.4	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	24.6	0.0	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.6	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.4	0.5	0.5	0.6	0.6	0.4	0.4	0.4
INSL5		ENSG00000172410	"Insulin like 5"	Q9Y5Q6	1	66797741-66801256	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	28	"intestine: 52.9"	"Cell line enhanced"	"Detected in some"		"HEK 293: 1.4;hTCEpi: 1.1"	"Group enriched"	"Detected in some"	5	"colorectal cancer: 1.2;prostate cancer: 0.7"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA030100, CAB033849"	Enhanced				"Secreted to blood"					"CAB033849: AB_2264904, HPA030100: AB_10601915"	"unprognostic (2.48e-1)"		"unprognostic (4.41e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.18e-1)"					"unprognostic (2.76e-2)"		"unprognostic (1.30e-1)"	"unprognostic (2.62e-2)"			"unprognostic (7.53e-2)"		0.0	0.0	0.8	0.0	1.3	0.0	0.0	0.1	1.0	0.0	30.8			0.0	0.0	0.0	0.0	0.7	0.0	0.0	1.1	1.8	0.4	0.0	0.0	0.0	0.5		0.0	0.0	0.0	0.5	0.0		0.2	52.9		0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.9			0.2		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
MYO1A	"DFNA48, MYHL"	ENSG00000166866	"Myosin IA"	Q9UBC5	12	57028517-57051198	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	27	"intestine: 148.0"	"Cell line enhanced"	"Detected in some"		"BEWO: 3.0;CACO-2: 11.9;Hep G2: 7.9;NB-4: 2.3"	"Group enriched"	"Detected in many"	13	"colorectal cancer: 17.8;pancreatic cancer: 4.8;stomach cancer: 9.8"	"Region enhanced"	"Detected in single"		"pons and medulla: 1.3"	"Group enriched"	"Detected in some"	5	"classical monocyte: 1.2;intermediate monocyte: 1.1;myeloid DC: 2.9"	"Group enriched"	"Detected in many"	6	"dendritic cells: 2.9;monocytes: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA053490	Enhanced		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA053490: AB_2682168"	"unprognostic (2.77e-2)"	"unprognostic (2.00e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.20e-1)"	"unprognostic (7.31e-2)"	"unprognostic (7.11e-2)"	"unprognostic (4.57e-2)"	"unprognostic (1.57e-1)"	"unprognostic (6.04e-2)"	"unprognostic (4.26e-2)"	"unprognostic (8.96e-2)"	"unprognostic (2.14e-1)"	"unprognostic (2.38e-2)"	"unprognostic (6.89e-2)"	"unprognostic (5.01e-1)"	"unprognostic (5.81e-2)"	"unprognostic (8.72e-2)"	0.1	0.1	0.1	5.2	0.2	0.0	0.1	0.1	0.2	0.1	57.2	0.3	0.1	70.0	0.1	0.1	0.1	0.1	5.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.5	0.1	0.1	0.1	0.0	0.1	0.2	1.3	0.1	14.1	0.1	0.2	0.1	0.1	0.1	148.0	0.4	4.7	0.1	3.3	0.3	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.0	2.9	0.0	1.2	0.0	0.3	0.1	0.0	0.4	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.2	0.0	11.9	0.7	0.6	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	7.9	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.7	2.3	0.1	0.0	0.0	0.0	1.5	0.0	0.0	0.8	0.7	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.2	1.4	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	1.2	0.0	0.0	1.1	0.3	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.2	0.1	0.2	0.1	0.1	0.5	0.1	1.3	0.1
SSU72P4		ENSG00000283873	"SSU72 pseudogene 4"		11	4287499-4288083	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in single"	24	"intestine: 2.4"	"Cell line enriched"	"Detected in single"	16	"U-2 OS: 1.5"									"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	2.4		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
ADGRG4	"GPR112, PGR17, RP1-299I16"	ENSG00000156920	"Adhesion G protein-coupled receptor G4"	Q8IZF6	X	136300963-136416888	"G-protein coupled receptors, Plasma proteins, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	21	"intestine: 23.6"	"Cell line enhanced"	"Detected in single"		"TIME: 3.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA035324	Uncertain									"HPA035324: AB_10671512"											"unprognostic (3.40e-3)"		"unprognostic (7.68e-5)"	"unprognostic (7.61e-2)"				0.4	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	12.9	0.0	0.0	7.1	0.7	1.1	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.1	0.1	0.0	23.6	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.8	0.6	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MUC13	DRCC1	ENSG00000173702	"Mucin 13, cell surface associated"	Q9H3R2	3	124905442-124953819	"Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	20	"intestine: 334.4"	"Cell line enhanced"	"Detected in some"		"A549: 8.0;CACO-2: 6.9;CAPAN-2: 14.9;Karpas-707: 8.7"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 198.4;stomach cancer: 152.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045163	Enhanced				"Secreted to digestive system"					"HPA045163: AB_10960396"	"unprognostic (8.42e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.55e-3)"	"unprognostic (2.93e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.48e-2)"	"unprognostic (2.94e-1)"	"unprognostic (5.10e-2)"	"unprognostic (2.02e-1)"	"unprognostic (9.64e-2)"	"prognostic unfavourable (9.73e-5)"	"unprognostic (2.05e-3)"	"unprognostic (1.10e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.42e-1)"	0.5	0.6	0.5	16.4	0.5	0.0	0.5	0.5	0.5	0.5	83.1	0.0	0.0	79.9	0.5	0.3	0.5	0.5	16.7	0.5	0.5	0.5	3.3	8.7	0.5	0.0	0.5	0.0	0.5	1.8	0.0	0.5	0.1	0.1	0.5	40.6	0.1	0.5	0.0	0.5	0.5	334.4	1.0	0.5	0.5	4.1	0.5	0.0	0.1	0.5	0.0	0.1	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0	0.0	1.2	1.0	0.0	0.0	0.1	6.9	14.9	0.0	0.9	0.2	1.1	0.0	0.0	0.0	0.1	0.2	0.0	1.7	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.1	0.0	0.0	1.1	0.0	1.2	0.1	0.1	2.7	0.0	0.0	0.3	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	2.4	0.1	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.5	0.5	0.5	0.5	0.5	0.0	0.1	0.0
MUC2		ENSG00000198788	"Mucin 2, oligomeric mucus/gel-forming"		11	1074875-1110511	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"				"Tissue enriched"	"Detected in some"	20	"intestine: 28.1"	"Cell line enhanced"	"Detected in some"		"NB-4: 1.0;RPMI-8226: 1.0;RT4: 2.6"	"Group enriched"	"Detected in many"	13	"colorectal cancer: 93.2;pancreatic cancer: 27.7;stomach cancer: 21.9"					"Not detected"	"Not detected"			"Not detected"	"Not detected"											CAB016275	Enhanced				"Intracellular and membrane"					"CAB016275: AB_627970"	"unprognostic (6.37e-2)"	"unprognostic (8.32e-2)"	"unprognostic (5.76e-3)"	"unprognostic (5.09e-2)"	"unprognostic (6.18e-3)"	"unprognostic (3.39e-2)"	"unprognostic (1.71e-2)"	"unprognostic (5.76e-3)"	"unprognostic (7.87e-2)"	"unprognostic (2.04e-1)"	"unprognostic (7.37e-3)"	"unprognostic (4.20e-2)"	"unprognostic (3.64e-5)"	"unprognostic (1.38e-1)"	"unprognostic (1.22e-1)"		"unprognostic (3.10e-2)"	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	28.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	11.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	1.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
GUCY2C	"GUC2C, STAR"	ENSG00000070019	"Guanylate cyclase 2C"	P25092	12	14612632-14696585	"Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	19	"intestine: 85.1"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 3.7;BEWO: 2.2;CACO-2: 3.1;CAPAN-2: 4.5;SiHa: 4.2"	"Group enriched"	"Detected in many"	5	"colorectal cancer: 23.9;stomach cancer: 9.1"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 4.3"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA037655, HPA073759"	Uncertain		Uncertain	Vesicles				Vesicles	Vesicles	"HPA037655: AB_10672388, HPA073759: "	"unprognostic (1.08e-1)"	"unprognostic (2.12e-1)"	"unprognostic (3.58e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.60e-2)"	"unprognostic (5.67e-3)"	"prognostic unfavourable (1.37e-5)"	"unprognostic (9.14e-2)"	"unprognostic (1.49e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.58e-1)"	"unprognostic (5.40e-2)"	"unprognostic (2.35e-4)"	"unprognostic (8.02e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.98e-1)"	0.2	0.1	0.2	3.4	0.2	0.0	0.2	0.2	0.2	0.2	38.8	0.2	0.2	28.0	0.3	0.2	0.4	0.2	0.3	0.4	0.2	0.1	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.5	0.0	0.2	0.2	0.2	0.2	17.5	0.2	0.5	0.2	0.2	1.0	85.1	0.3	0.2	0.2	0.5	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.3	4.3	0.7	2.7	1.7	0.0	0.0	0.6	1.1	0.1	0.0	3.7	0.0	0.0	2.2	0.1	0.0	0.0	0.0	3.1	4.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.7	0.0	0.4	0.4	0.0	0.0	0.0	0.5	0.1	0.6	0.0	0.5	4.2	0.3	0.0	0.3	0.1	0.0	0.0	0.0	0.9	0.1	1.3	0.8	1.3	0.0	0.0	0.1	0.0	1.7	0.0	0.0	0.5	0.0	4.3	0.0	0.0	0.7	2.3	0.0	0.0	2.7	0.0	0.0	0.7	0.0	0.6	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2
GUCA2B		ENSG00000044012	"Guanylate cyclase activator 2B"	Q16661	1	42153421-42155824	"Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	18	"intestine: 92.4"	"Group enriched"	"Detected in some"	6	"A549: 3.3;CACO-2: 8.9"	"Cancer enhanced"	"Detected in many"		"liver cancer: 5.5"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	19	"intermediate monocyte: 1.9"	"Lineage enriched"	"Detected in single"	19	"monocytes: 1.9"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"cerebral cortex: 0.8;hippocampal formation: 0.5"						"Secreted to blood"	740000	740000						"unprognostic (2.59e-2)"				"unprognostic (1.44e-2)"				"unprognostic (1.34e-1)"		"unprognostic (6.22e-2)"	"unprognostic (1.86e-1)"				0.1	0.0	0.1	1.2	0.1	0.0	0.1	0.1	0.1	0.1	55.2	0.1	0.1	13.5	0.1	0.1	0.1	0.0	0.7	0.1	0.1	0.0	0.1	2.1	0.1	0.1	0.1	0.1	0.1	0.6	0.0	0.1	0.1	0.1	0.1	8.7	0.1	0.1	0.1	0.1	0.0	92.4	0.1	0.1	0.2	5.2	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	8.9	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
ASAH2		ENSG00000188611	"N-acylsphingosine amidohydrolase 2"	Q9NR71	10	50182778-50248610	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	17	"intestine: 43.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in single"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"											HPA061171	Supported		Approved	"Focal adhesion sites"	"Intracellular and membrane"	1200000	1200000	"Focal adhesion sites"	"Focal adhesion sites"	"HPA061171: AB_2684442"	"unprognostic (3.59e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.84e-2)"	"unprognostic (3.66e-1)"	"unprognostic (4.48e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.65e-2)"	"unprognostic (4.33e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.14e-1)"	"unprognostic (8.29e-2)"	"unprognostic (1.86e-2)"	"unprognostic (5.64e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.02e-3)"	0.3	1.1	0.6	0.2	0.9	0.0	0.5	0.5	1.3	1.7	0.5			43.9	0.7	0.3	0.7	0.5	0.2	0.9	0.5	1.4	0.6	1.6	0.4	0.2	1.2		1.4	1.5	0.3	1.0	0.4		0.5	0.3		0.9	0.2	0.8	0.7	33.4	0.7	0.6	0.2	2.5	1.1			0.6		0.1	1.0	0.5	0.9	0.9	0.0	0.0	0.0	2.2	0.1	1.8	1.4	1.6	2.2	2.9	1.1	2.0	2.0	1.3	3.8	3.5	1.0	4.6	0.0	2.2	2.7	1.7	2.1	0.7	4.7	2.3	3.8	1.3	3.8	2.9	1.8	0.4	0.2	0.4	2.6	6.5	7.4	0.8	2.5	1.2	2.5	1.5	1.4	0.1	4.8	4.1	0.0	6.4	1.6	2.1	0.3	2.7	7.3	2.5	1.8	3.3	1.5	1.0	2.0	1.9	4.3	4.7	6.0	1.9	0.2	0.0	5.5	0.0	1.7	0.0	0.0	0.0	0.7	0.0	2.2	0.9	0.4	1.7	0.0	0.1	1.4	2.1	0.0	0.0	0.0	0.9	0.6	0.1										
DHRS11	"MGC4172, SDR24C1"	ENSG00000278535	"Dehydrogenase/reductase 11"	Q6UWP2	17	36591798-36600806	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	15	"intestine: 88.0"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041226, HPA048236, HPA053623"	Enhanced		Approved	"Golgi apparatus,Cytosol"	"Intracellular and membrane"	11000	11000	Cytosol	Cytosol	"HPA041226: AB_2677372, HPA048236: AB_2680322, HPA053623: AB_2682209"	"unprognostic (2.00e-3)"	"unprognostic (1.22e-2)"	"unprognostic (1.06e-2)"	"unprognostic (3.74e-1)"	"unprognostic (1.61e-3)"	"unprognostic (2.03e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.80e-2)"	"unprognostic (3.67e-1)"	"unprognostic (5.94e-2)"	"unprognostic (1.33e-2)"	"unprognostic (4.11e-2)"	"prognostic favourable (3.24e-4)"	"unprognostic (1.45e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.16e-2)"	"unprognostic (9.35e-2)"	1.3	0.6	1.2	4.1	2.4	0.4	0.7	0.5	5.7	0.4	38.7	0.4	0.4	42.7	0.4	0.1	1.2	1.1	1.4	2.0	0.5		2.5	1.7	0.1	0.0	0.0	2.4	0.1	2.8	1.5	0.2	0.0	1.6	0.5	12.4	2.8	2.1	0.8	2.0	0.8	88.0	0.9	0.1	0.0	1.1	2.2	0.3	0.0	1.3	1.3	1.0	0.4	0.0	0.9	0.2	0.9	0.7	0.1	2.7	0.1	6.5	5.9	2.8	7.4	0.6	1.7	5.5	2.0	1.4	6.4	5.8	9.6	5.3	0.7	1.4	2.0	6.9	6.0	4.1	6.5	3.4	11.4	1.7	5.7	18.6	3.1	1.9	0.6	0.9	3.9	4.4	3.3	4.9	15.6	5.8	3.5	5.8	6.4	3.5	2.2	2.3	8.0	7.0	11.0	6.5	5.6	6.0	2.6	7.0	7.3	16.4	10.0	1.8	1.8	0.9	9.1	4.8	5.0	9.5	8.0	2.3	3.3	4.7	2.8	0.4	0.5	0.9	1.0	0.7	0.1	0.4	1.0	0.6	0.1	0.9	1.3	0.9	0.5	0.1	0.1	0.2	2.7	0.1										
HHLA2	"B7-H5, B7H7, B7y"	ENSG00000114455	"HERV-H LTR-associating 2"	Q9UM44	3	108296490-108378285	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	15	"intestine: 125.2"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 7.9;Karpas-707: 5.8"	"Group enriched"	"Detected in many"	12	"colorectal cancer: 9.2;lung cancer: 5.0;pancreatic cancer: 5.1;renal cancer: 16.6;stomach cancer: 6.2"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"myeloid DC: 5.1"	"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA055478	Enhanced									"HPA055478: AB_2682830"	"unprognostic (1.12e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.11e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.59e-2)"	"unprognostic (8.14e-5)"	"unprognostic (1.76e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.08e-1)"	"unprognostic (6.42e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.62e-3)"	"unprognostic (1.47e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.66e-2)"	0.2	0.2	0.3	4.3	0.3	0.0	0.2	0.2	0.3	0.3	39.6	0.2	0.2	25.5	0.2	0.5	0.2	0.9	8.5	0.2	0.3	0.3	7.8	0.4	2.2	0.2	0.3	0.2	0.6	1.2	0.0	0.3	0.2	0.2	0.2	25.2	0.2	0.2	0.2	0.2	0.1	125.2	0.3	0.5	0.3	2.5	1.9	0.2	0.2	0.2	0.2	0.3	0.2	0.2	0.3	5.1	1.2	1.5	0.3	0.5	0.7	0.4	0.6	0.4	0.5	0.0	0.0	1.5	0.0	0.0	0.0	0.5	3.5	0.4	0.3	0.4	0.1	0.4	1.2	0.0	0.0	7.9	0.2	0.2	2.7	0.5	0.0	1.7	1.0	0.0	0.0	0.0	0.0	0.1	0.7	5.8	0.0	0.5	0.8	3.0	1.2	0.6	0.7	0.3	1.6	0.1	0.3	1.4	1.4	1.4	0.1	0.3	0.3	0.4	0.3	0.3	1.5	0.5	0.4	3.1	1.4	0.8	0.1	0.9	0.2	1.2	0.3	1.1	0.1	0.4	0.1	0.3	0.2	0.5	5.1	0.3	0.2	0.1	0.5	0.3	1.5	0.1	0.0	0.7	0.3	0.3	0.2	0.3	0.3	0.3	0.3	0.2	0.2	0.2
MYRFL	"bcm1377, C12orf15, C12orf28, FLJ25056"	ENSG00000166268	"Myelin regulatory factor-like"	Q96LU7	12	69825304-69959097	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	15	"intestine: 56.1"	"Cell line enhanced"	"Detected in some"		"NTERA-2: 6.8;SK-BR-3: 3.4;T-47d: 15.4"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in single"	5	"cerebellum: 3.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA049340	Approved		Approved	Nucleoli	"Intracellular and membrane"			Nucleoli	Nucleoli	"HPA049340: AB_2680719"	"unprognostic (2.95e-2)"	"unprognostic (6.25e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.42e-1)"	"unprognostic (5.18e-2)"	"unprognostic (2.34e-1)"	"unprognostic (5.45e-2)"	"unprognostic (6.50e-2)"	"unprognostic (3.37e-1)"	"unprognostic (2.65e-1)"	"unprognostic (3.08e-1)"	"unprognostic (8.99e-2)"	"unprognostic (1.91e-2)"	"unprognostic (3.89e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.17e-1)"	"unprognostic (9.96e-2)"	0.3	0.3	0.5	0.0	0.6	0.0	0.5	3.6	0.6	0.1	20.7	0.0	0.4	21.4	0.1	0.9	0.1	0.1	0.7	0.2	0.4	0.2	2.0	0.3	0.2	0.2	0.5	0.2	0.0	0.8	0.0	1.0	0.3	0.7	0.6	0.1	0.3	1.3	0.4	0.0	1.6	56.1	0.1	1.0	0.1	0.1	2.4	0.5	0.0	0.1	0.2	0.3	0.0	0.0	0.0	0.7	0.0	0.9	0.0	0.0	0.1	0.0	0.1	0.4	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.1	0.1	0.8	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.2	0.2	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	6.8	0.0	0.1	0.0	1.1	1.0	0.0	0.3	0.1	0.0	3.4	0.0	15.4	0.0	0.0	0.0	0.0	0.0	0.1	0.3	1.4	0.9	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.6	3.6	0.6	0.4	0.2	0.5	0.2	0.7	0.5
TMEM236	"bA162I21.2, bA16O1.2, FAM23A, FAM23B"	ENSG00000148483	"Transmembrane protein 236"	Q5W0B7	10	17752252-17800868	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	15	"intestine: 76.4"	"Cell line enriched"	"Detected in some"	10	"MOLT-4: 14.9"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 1.7"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA045096	Enhanced									"HPA045096: AB_2732516"	"unprognostic (4.95e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.88e-3)"	"unprognostic (2.47e-1)"	"unprognostic (1.96e-1)"	"unprognostic (3.36e-2)"	"unprognostic (2.52e-3)"	"unprognostic (1.37e-1)"	"unprognostic (3.98e-1)"	"unprognostic (1.42e-1)"	"unprognostic (5.06e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.72e-1)"	"unprognostic (3.43e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.54e-2)"	0.5	0.3	0.3	4.9	0.3	0.0	0.3	0.3	0.3	0.4	32.0	0.1	0.1	13.7	0.5	0.1	0.4	0.2	0.1	0.3	0.3	0.3	0.5	0.4	0.6	0.1	0.3	0.1	0.3	0.7	0.0	0.3	0.6	0.1	0.3	9.1	0.1	0.3	0.1	0.5	0.3	76.4	0.3	0.3	0.3	0.3	0.5	0.1	0.1	0.3	0.1	0.1	0.3	0.3	1.3	0.9	2.6	0.6	1.0	0.6	0.1	0.3	0.2	0.4	0.5	0.1	0.1	0.5	0.3	0.0	0.1	0.3	0.5	0.5	0.2	0.2	0.2	0.3	0.2	0.2	0.8	0.2	0.5	0.6	0.5	0.5	0.1	0.5	1.5	0.2	0.4	0.1	0.2	0.4	0.2	0.4	0.2	0.3	14.9	0.3	0.3	0.1	0.6	0.4	0.3	0.1	0.3	0.3	0.2	0.2	0.1	0.5	0.2	0.0	0.7	0.5	0.6	0.2	0.2	0.3	0.2	0.3	0.2	0.2	0.2	2.6	0.6	0.9	0.6	0.4	0.4	0.7	0.5	0.4	0.4	1.3	0.5	0.6	2.2	1.0	0.4	0.9	0.4	0.1	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.1	0.1	0.1
C11orf86	FLJ22675	ENSG00000173237	"Chromosome 11 open reading frame 86"	A6NJI1	11	66975277-66977004	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	14	"intestine: 57.7"	"Group enriched"	"Detected in some"	5	"HeLa: 6.7;SiHa: 22.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA039348	Uncertain									"HPA039348: AB_10673421"		"unprognostic (1.54e-2)"	"unprognostic (7.67e-3)"		"unprognostic (3.02e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.90e-4)"	"prognostic unfavourable (8.97e-4)"		"unprognostic (4.17e-1)"	"prognostic unfavourable (6.97e-5)"		"prognostic unfavourable (1.02e-5)"	"unprognostic (7.04e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.69e-2)"	"unprognostic (3.58e-3)"	0.1	4.0	0.1	1.1	0.1	0.0	0.1	0.1	0.1	0.1	24.4	0.1	0.1	33.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.5	1.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	2.1	0.1	0.1	3.0	0.1	0.1	0.1	0.1	0.0	57.7	0.2	0.1	0.1	1.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	22.8	3.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
PLS1	"I-plastin, Plastin-1"	ENSG00000120756	"Plastin 1"	Q14651	3	142596387-142713664	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	14	"intestine: 193.0"	"Cell line enhanced"	"Detected in many"		"A-431: 27.4;BEWO: 36.0;RPTEC TERT1: 45.9;RT4: 25.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"granulocytes: 4.9;NK-cells: 5.9;T-cells: 5.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055744	Enhanced					50000000	50000000			"HPA055744: AB_2682903"	"unprognostic (1.29e-1)"	"unprognostic (2.61e-1)"	"unprognostic (3.15e-3)"	"unprognostic (2.22e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.13e-1)"	"unprognostic (6.82e-2)"	"unprognostic (2.33e-1)"	"unprognostic (7.78e-2)"	"prognostic unfavourable (4.84e-4)"	"unprognostic (3.14e-2)"	"prognostic favourable (8.76e-6)"	"unprognostic (1.99e-2)"	"unprognostic (8.64e-2)"	"unprognostic (7.22e-2)"	"unprognostic (3.82e-2)"	0.5	2.3	1.0	8.2	1.0	1.0	1.7	1.5	2.0	2.0	42.3	0.6	0.2	40.0	0.5	1.1	5.7	1.3	6.3	0.9	1.2	1.1	12.5	10.6	4.4	0.3	0.9	1.0	0.6	5.0	3.8	13.6	0.8	4.5	1.8	30.0	2.9	5.3	0.9	0.5	1.2	193.0	0.6	1.2	0.5	9.6	2.6	0.5	2.5	3.7	1.3	1.6	5.1	2.3	0.7	0.9	4.9	0.4	5.9	5.0	1.8	27.4	21.6	1.5	3.3	0.2	0.0	36.0	0.5	0.7	3.0	6.5	9.8	21.7	4.7	11.5	0.1	5.9	5.9	9.0	6.4	1.7	8.5	8.3	3.4	3.5	0.2	3.9	0.5	0.1	1.5	5.7	3.7	1.4	3.5	0.5	0.3	6.4	6.4	2.1	6.0	8.2	2.6	6.5	3.8	45.9	25.4	7.7	3.1	3.1	2.2	2.5	17.7	0.7	0.3	0.3	3.7	1.1	6.6	4.1	3.8	5.5	1.0	3.9	1.1	3.4	0.4	4.9	2.9	0.3	3.8	0.7	3.5	3.8	0.7	0.6	4.3	5.0	3.3	5.9	0.4	0.9	2.1	1.8	1.0	1.0	1.5	2.0	1.2	1.1	0.9	1.0	4.5	0.5
SOAT2	ACAT2	ENSG00000167780	"Sterol O-acyltransferase 2"	O75908	12	53103518-53124538	"Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"intestine: 60.8"	"Group enriched"	"Detected in some"	5	"CACO-2: 9.6;Hep G2: 20.9;U-266/70: 7.0"	"Group enriched"	"Detected in some"	8	"liver cancer: 5.2;testis cancer: 5.5"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"MAIT T-cell: 3.7;memory CD4 T-cell: 1.5;memory CD8 T-cell: 2.7;naive CD8 T-cell: 1.5"	"Lineage enriched"	"Detected in single"	7	"T-cells: 3.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"														"unprognostic (2.53e-1)"	"unprognostic (2.72e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.30e-4)"	"unprognostic (3.88e-3)"	"unprognostic (9.26e-2)"	"unprognostic (4.20e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.83e-2)"	"unprognostic (9.05e-2)"	"unprognostic (2.37e-1)"	"unprognostic (7.58e-3)"	"unprognostic (3.28e-1)"	0.5	0.0	0.2	0.2	0.2	0.2	0.6	0.2	0.2	0.9	16.4	0.2	0.2	12.3	0.7	0.3	0.2	0.9	0.4	0.2	0.2	0.0	0.6	4.2	0.2	0.6	0.2	0.2	0.4	0.2	0.0	0.3	0.2	0.2	0.6	0.0	0.2	0.4	0.2	0.2	0.4	60.8	0.2	0.3	2.2	0.3	0.2	0.2	0.2	0.4	0.2	0.3	0.3	1.1	0.0	0.0	0.0	0.3	0.5	3.7	0.2	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.3	0.4	9.6	0.1	0.0	0.0	0.4	0.7	0.0	0.0	0.6	0.0	0.0	0.9	0.0	20.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	7.0	1.5	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	3.7	0.0	1.5	2.7	0.0	0.0	0.4	1.5	0.0	0.5	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2
TBX10	"TBX13, TBX7"	ENSG00000167800	"T-box 10"	O75333	11	67631303-67639560	"Predicted intracellular proteins, Transcription factors"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	14	"intestine: 12.1"	"Cell line enhanced"	"Detected in some"		"Daudi: 2.9;NTERA-2: 6.6;RPMI-8226: 4.3;SK-BR-3: 15.5;U-2 OS: 3.3"	"Group enriched"	"Detected in some"	5	"breast cancer: 0.8;colorectal cancer: 2.6;liver cancer: 0.5;prostate cancer: 1.9;stomach cancer: 0.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	7	"pons and medulla: 0.4"	"Low region specificity"	"Detected in many"			HPA047881	Uncertain				"Intracellular and membrane"					"HPA047881: AB_2680199"	"unprognostic (4.66e-2)"	"unprognostic (2.96e-2)"	"unprognostic (7.71e-3)"	"unprognostic (1.79e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.83e-4)"	"unprognostic (3.12e-1)"	"unprognostic (3.29e-2)"		"unprognostic (5.10e-2)"	"unprognostic (1.83e-1)"	"unprognostic (4.90e-1)"	"unprognostic (1.17e-10)"	"unprognostic (6.77e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.95e-1)"	"unprognostic (2.75e-1)"	0.2	0.0	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	9.9	0.2	0.2	6.4	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.0	0.2	0.8	0.2	0.2	0.2	0.2	0.2	0.4	0.0	0.2	0.2	0.2	0.2	9.1	0.2	0.4	0.2	0.2	0.0	12.1	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.5	0.0	0.0	0.1	0.5	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	6.6	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.1	0.0	15.5	0.0	0.0	0.1	0.0	0.0	3.3	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2
ASIC5	"ACCN5, HINAC, INAC"	ENSG00000256394	"Acid sensing ion channel subunit family member 5"	Q9NY37	4	155829729-155866273	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in single"	13	"intestine: 7.3"	"Cell line enhanced"	"Detected in single"		"Karpas-707: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA014903, HPA029444"	Approved									"HPA014903: AB_1844498, HPA029444: AB_10611671"					"unprognostic (8.52e-5)"		"unprognostic (2.52e-1)"	"unprognostic (1.25e-1)"									"unprognostic (4.05e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.4	0.0	0.0	7.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	6.3	0.0	0.2	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0
CLDN15		ENSG00000106404	"Claudin 15"	P56746	7	101232092-101238820	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	13	"intestine: 194.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"														"unprognostic (8.85e-2)"	"unprognostic (1.48e-1)"	"unprognostic (4.93e-2)"	"unprognostic (3.66e-1)"	"unprognostic (1.11e-1)"	"unprognostic (6.81e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.03e-1)"	"unprognostic (6.56e-2)"	"unprognostic (1.79e-1)"	"prognostic favourable (2.56e-4)"	"unprognostic (2.02e-2)"	"prognostic unfavourable (5.31e-5)"	"unprognostic (9.98e-2)"	"unprognostic (2.89e-2)"	"unprognostic (9.64e-2)"	"prognostic favourable (3.30e-4)"	15.4	0.7	1.0	5.2	1.0	3.9	12.5	1.3	1.1	2.5	172.9	1.1	1.2	76.6	2.4	4.4	1.8	3.2	7.2	2.1	1.7	0.8	3.7	7.0	2.2	2.9	1.7	0.8	4.4	1.3	1.1	1.3	2.0	1.7	2.2	2.4	0.8	1.4	1.2	1.1	2.1	194.8	1.6	2.3	5.7	1.7	2.4	1.4	1.0	1.8	1.3	2.3	2.7	3.0	1.0	1.8	1.7	1.2	0.8	1.9	1.4	2.1	6.7	3.6	5.6	5.7	4.6	2.5	2.1	2.7	2.7	3.9	4.5	2.6	7.3	3.8	1.4	4.1	5.9	1.2	2.7	9.0	12.7	3.3	3.8	5.8	5.0	3.7	7.3	4.4	6.0	3.5	4.6	2.2	15.6	11.8	2.0	7.5	5.9	21.4	2.8	4.7	8.0	3.1	6.0	1.6	2.7	3.5	12.4	1.9	3.7	10.4	3.4	7.5	3.2	8.8	7.7	13.3	2.6	12.5	15.7	7.7	2.5	9.8	5.1	0.2	1.2	0.1	1.9	0.7	0.6	0.4	1.9	0.2	0.8	1.0	1.3	1.4	1.7	0.8	0.9	1.8	0.8	1.4	1.0	1.0	1.3	1.0	1.7	0.8	1.7	0.8	1.7	1.4
MALRD1	"bA265G8.2, C10orf112, Diet1"	ENSG00000204740	"MAM and LDL receptor class A domain containing 1"	Q5VYJ5	10	19048771-19790401	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	13	"intestine: 60.5"	"Cell line enriched"	"Detected in some"	10	"Karpas-707: 31.2"	"Cancer enhanced"	"Detected in some"		"stomach cancer: 1.1"	"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	5	"plasmacytoid DC: 3.6"	"Lineage enriched"	"Detected in single"	17	"dendritic cells: 3.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA035732, HPA038106, HPA046848"	Uncertain		Enhanced	"Golgi apparatus"				"Golgi apparatus"	"Golgi apparatus"	"HPA035732: AB_2674756, HPA038106: AB_2675836, HPA046848: AB_2679837"	"unprognostic (9.03e-3)"	"unprognostic (1.38e-1)"	"unprognostic (2.40e-2)"	"unprognostic (4.05e-3)"	"unprognostic (2.49e-1)"	"unprognostic (3.77e-1)"	"unprognostic (2.74e-2)"	"unprognostic (5.57e-2)"	"unprognostic (5.01e-1)"	"unprognostic (1.00e-1)"	"unprognostic (3.55e-1)"	"unprognostic (7.69e-2)"	"unprognostic (3.16e-2)"	"unprognostic (9.80e-2)"	"unprognostic (8.90e-2)"	"unprognostic (3.13e-2)"	"unprognostic (3.78e-4)"	0.5	0.8	2.0	0.3	2.0	0.4	0.6	0.3	0.9	0.8	19.4	0.6	0.1	25.2	1.3	2.3	0.3	0.3	0.4	1.3	1.6	0.8	1.3	0.3	0.9	0.2	0.8	0.0	1.1	0.3	0.1	4.7	0.4	0.8	0.9	0.2	1.4	0.5	0.4	0.5	0.4	60.5	1.3	0.7	0.3	0.5	1.7	0.7	2.6	0.6	0.3	0.1	0.5	0.5	0.0	3.6	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.6	0.0	1.7	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	31.2	0.0	3.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.1	0.0	3.6	0.0	0.0	2.0	2.0	0.3	0.9	1.6	0.8	0.8	0.0	0.8	0.7
CDX2	CDX3	ENSG00000165556	"Caudal type homeobox 2"	Q99626	13	27962137-27971139	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"intestine: 21.2"	"Group enriched"	"Detected in some"	6	"CACO-2: 14.4;CAPAN-2: 4.8;HEK 293: 8.0"	"Cancer enriched"	"Detected in many"	6	"colorectal cancer: 63.7"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB002221, HPA045669, HPA049580"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm	Nucleoplasm	"CAB002221: AB_563649, HPA045669: AB_2679413, HPA049580: "		"unprognostic (1.42e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.92e-1)"		"unprognostic (8.11e-3)"	"unprognostic (4.19e-6)"	"unprognostic (1.73e-4)"		"unprognostic (1.71e-1)"	"unprognostic (1.58e-1)"	"unprognostic (5.51e-2)"		"unprognostic (6.07e-3)"	"unprognostic (1.13e-1)"		"unprognostic (1.09e-1)"	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	21.2			13.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	1.6	0.0	0.0	0.0		0.1	14.3		0.0	0.0	0.0	0.0	16.3	0.3	0.0	0.0	0.0	0.0			0.0		0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	14.4	4.8	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	8.0	0.0	0.2	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CEACAM20	UNQ9366	ENSG00000273777	"Carcinoembryonic antigen related cell adhesion molecule 20"		19	44501677-44529788	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in some"	11	"intestine: 64.6"	"Cell line enriched"	"Detected in single"	7	"U-266/70: 5.5"	"Group enriched"	"Detected in some"	9	"liver cancer: 1.2;prostate cancer: 5.3"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"														"unprognostic (1.04e-2)"	"unprognostic (5.03e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.92e-1)"			"unprognostic (1.23e-2)"	"unprognostic (3.75e-1)"		"unprognostic (9.89e-2)"	"unprognostic (1.07e-2)"	"unprognostic (7.58e-2)"	"unprognostic (2.14e-5)"	"unprognostic (7.13e-2)"	"unprognostic (2.51e-2)"		"unprognostic (1.44e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.0	0.0	0.0	23.9	0.0	0.0	0.0	0.0	1.1	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	64.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.1	0.0	5.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CHST5	"FLJ22167, I-GLCNAC-6-ST"	ENSG00000135702	"Carbohydrate sulfotransferase 5"	Q9GZS9	16	75528535-75535247	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"intestine: 32.9"	"Cell line enhanced"	"Detected in many"		"PC-3: 4.6"	"Group enriched"	"Detected in some"	6	"colorectal cancer: 1.4;stomach cancer: 1.5"	"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA043804	Enhanced				"Intracellular and membrane"					"HPA043804: AB_10960563"	"unprognostic (6.82e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.99e-3)"	"unprognostic (1.03e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.46e-2)"		"unprognostic (6.76e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.09e-2)"	"unprognostic (9.03e-3)"	"unprognostic (4.27e-2)"	"unprognostic (2.05e-3)"	"unprognostic (3.56e-1)"	"unprognostic (2.52e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.42e-2)"	0.4	0.0	0.7	0.4	1.7	0.0	0.4	2.4	1.1	0.4	17.5	0.4	0.4	32.9	0.4	0.4	0.4	1.1	0.4	0.4	0.8	0.8	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.0	0.5	0.4	0.4	0.4	21.6	0.4	0.4	0.4	2.1	0.0	28.5	0.4	0.4	0.4	1.7	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.4	1.3	1.1	3.0	1.3	1.1	1.1	0.4	0.4	1.0	1.4	1.6	0.4	0.9	0.7	0.0	0.3	0.6	0.5	0.6	1.9	1.2	0.6	0.3	1.1	0.1	0.7	0.0	0.4	1.4	0.2	0.5	1.8	0.3	0.7	0.8	1.1	0.1	0.0	0.4	0.2	0.4	1.3	0.0	2.7	0.7	3.7	0.9	4.6	0.5	0.4	2.6	1.6	0.4	2.1	3.6	1.9	1.4	0.2	1.0	0.3	0.3	1.5	1.0	2.6	0.3	0.7	1.8	0.2	1.0	0.3	0.9	3.0	1.0	1.0	0.9	1.0	0.8	1.0	0.8	0.7	0.5	1.3	1.1	1.1	2.6	1.1	1.3	1.1	0.7	0.4	0.7	1.7	2.4	1.1	0.8	0.8	0.4	0.4	0.4	0.4
DQX1	FLJ23757	ENSG00000144045	"DEAQ-box RNA dependent ATPase 1"	Q8TE96	2	74518131-74526336	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"intestine: 41.0"	"Group enriched"	"Detected in some"	4	"HBEC3-KT: 6.4;Hep G2: 18.0;hTCEpi: 6.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.4"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA039158	Enhanced		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA039158: AB_10960125"	"unprognostic (2.17e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.20e-2)"	"unprognostic (9.95e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.18e-1)"	"unprognostic (6.49e-2)"	"unprognostic (3.93e-1)"	"unprognostic (4.54e-2)"	"unprognostic (1.68e-1)"	"unprognostic (7.67e-2)"	"unprognostic (2.21e-2)"	"unprognostic (0.00e+0)"	"unprognostic (1.13e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.29e-1)"	"unprognostic (6.16e-3)"	0.1	0.0	0.1	2.1	0.2	0.0	0.1	0.1	0.1	0.8	13.3	0.2	0.1	14.7	0.1	0.1	3.7	0.2	3.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	1.0	0.1	0.2	5.1	0.1	0.6	0.1	0.1	1.5	41.0	0.3	0.1	0.2	2.9	0.1	0.1	0.2	0.1	0.7	1.5	1.1	1.4	0.7	1.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.1	0.5	0.1	0.3	0.0	0.0	0.7	0.1	6.4	0.1	0.0	0.3	0.4	0.1	18.0	0.0	0.2	0.3	0.0	6.6	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.2	0.3	0.0	0.1	0.1	0.1	0.0	1.2	0.0	0.1	0.0	2.5	0.0	0.6	0.0	0.0	0.8	0.2	0.1	0.0	0.1	0.2	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1
HNF4G	NR2A2	ENSG00000164749	"Hepatocyte nuclear factor 4 gamma"	Q14541	8	75407914-75566843	"Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"intestine: 139.6"	"Cell line enhanced"	"Detected in some"		"A549: 4.6;CAPAN-2: 17.3;Karpas-707: 4.9;PC-3: 5.3;THP-1: 5.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	13	"gdTCR: 1.3"	"Lineage enriched"	"Detected in single"	13	"T-cells: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA005438, HPA010610"	Enhanced		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA005438: AB_1850822, HPA010610: AB_2668318"	"unprognostic (2.09e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.77e-2)"	"unprognostic (9.44e-2)"	"unprognostic (5.60e-2)"	"unprognostic (4.65e-2)"	"unprognostic (5.26e-2)"	"unprognostic (1.27e-2)"	"unprognostic (3.92e-1)"	"unprognostic (8.09e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.83e-2)"	"unprognostic (6.93e-3)"	"unprognostic (1.67e-2)"	"unprognostic (2.11e-1)"	"unprognostic (4.22e-2)"	"unprognostic (2.47e-2)"	0.2	0.2	0.5	5.0	0.5	0.0	0.3	0.3	0.3	0.6	56.2	0.1	0.3	35.9	0.4	1.1	0.4	0.3	12.6	0.2	0.3	0.3	6.1	12.1	0.4	0.0	0.4	0.2	0.2	10.9	0.0	0.2	0.0	0.3	0.6	6.9	0.2	0.4	0.6	0.2	0.2	139.6	0.2	0.3	0.2	2.6	0.9	0.1	0.1	0.2	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	1.3	0.0	1.1	4.6	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.3	17.3	0.0	2.5	0.0	0.0	2.2	0.0	0.0	0.0	1.9	0.0	0.0	3.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	4.9	0.0	0.0	0.0	0.3	0.3	5.3	0.0	0.0	0.3	3.0	0.1	0.3	1.7	0.4	0.1	0.0	0.3	5.8	0.0	0.4	0.2	0.1	0.0	1.2	0.0	0.0	0.4	0.0	0.8	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.3	0.3	0.3	0.3	0.4	0.2	0.3	0.1
ISX	RAXLX	ENSG00000175329	"Intestine specific homeobox"	Q2M1V0	22	35066136-35087387	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	11	"intestine: 22.2"	"Group enriched"	"Detected in some"	15	"CACO-2: 3.4;Hep G2: 9.6"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 6.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			HPA060328			Supported	"Nucleoplasm,Nuclear bodies"				Nucleoplasm	Nucleoplasm	"HPA060328: AB_2684254"			"unprognostic (5.02e-2)"				"unprognostic (2.68e-1)"				"unprognostic (2.23e-1)"	"unprognostic (3.33e-1)"		"unprognostic (3.86e-1)"	"unprognostic (2.55e-1)"			0.1	0.0	0.1	2.0	0.1	0.0	0.1	0.1	0.1	0.1	16.3	0.1	0.1	22.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.2	15.8	0.1	0.1	0.1	0.1	0.0	19.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	9.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
LINC00483	"C17orf73, FLJ20694"	ENSG00000167117	"Long intergenic non-protein coding RNA 483"		17	50761029-50767557	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in some"	11	"intestine: 73.0"	"Group enriched"	"Detected in some"	5	"CACO-2: 12.6;HDLM-2: 9.4"	"Group enriched"	"Detected in some"	12	"colorectal cancer: 3.3;pancreatic cancer: 0.8;stomach cancer: 2.0"					"Cell type enhanced"	"Detected in some"		"neutrophil: 6.5"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 6.5"	"Region enhanced"	"Detected in single"		"basal ganglia: 0.4"	"Low region specificity"	"Detected in all"														"unprognostic (2.98e-1)"		"unprognostic (1.96e-2)"	"unprognostic (2.02e-3)"			"unprognostic (2.76e-1)"	"unprognostic (4.52e-1)"		"unprognostic (1.95e-1)"	"unprognostic (2.09e-2)"	"unprognostic (8.37e-2)"	"unprognostic (1.57e-2)"	"unprognostic (6.81e-2)"	"unprognostic (1.67e-1)"		"unprognostic (1.05e-3)"	0.1	0.0	0.1	4.6	0.1	0.7	0.1	0.1	0.1	0.1	28.3	0.1	0.1	27.1	0.1	0.1	0.1	0.0	2.2	0.1	0.1		0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	9.7	0.1	0.1	0.1	0.1	0.2	73.0	0.1	0.1	0.1	0.8	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	1.1	0.8	6.5	1.5	0.9	0.9	0.4	0.6	1.0	0.6	1.4	0.0	0.6	1.2	0.5	0.0	0.0	0.0	12.6	0.8	0.3	0.3	0.3	0.8	0.0	0.2	0.1	9.4	0.8	0.7	2.1	1.6	0.0	0.7	1.9	0.6	0.1	0.2	0.0	0.0	0.2	0.9	0.0	0.5	0.4	1.3	0.2	0.5	0.9	0.6	0.5	0.1	2.1	0.4	1.0	0.5	1.0	0.1	1.2	0.0	1.0	1.2	0.7	0.8	0.4	0.5	0.4	1.0	0.4	0.4	0.5	4.6	1.5	0.8	0.7	0.8	0.4	0.7	0.7	0.7	0.2	1.1	0.9	0.6	6.5	0.9	0.8	0.8	0.5	0.4										
SLC13A2	NaDC-1	ENSG00000007216	"Solute carrier family 13 member 2"	Q13183	17	28473293-28497781	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"intestine: 181.4"	"Cell line enhanced"	"Detected in some"		"CACO-2: 2.0;RPMI-8226: 2.3;SH-SY5Y: 1.2;SK-BR-3: 1.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"hippocampal formation: 1.8"	HPA014963	Enhanced									"HPA014963: AB_1857096"	"unprognostic (8.47e-2)"	"unprognostic (7.63e-3)"	"unprognostic (4.36e-3)"	"unprognostic (2.06e-1)"		"unprognostic (2.36e-3)"	"unprognostic (3.06e-1)"	"unprognostic (2.28e-4)"		"unprognostic (1.50e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.00e-2)"	"prognostic favourable (9.00e-4)"	"unprognostic (2.16e-1)"	"unprognostic (2.64e-1)"		"unprognostic (1.50e-2)"	0.1	0.1	0.1	0.0	0.1	0.0	1.4	0.1	0.1	0.1	142.8	0.0	10.7	34.6	0.1	0.5	0.1	0.1	3.4	0.1	0.1	0.1	12.5	0.3	0.4	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.2	1.8	0.0	14.9	17.1	0.1	2.1	181.4	0.0	0.1	0.1	0.1	0.2	0.0	0.0	0.1	0.7	0.1	0.2	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	1.2	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
SLC5A1	"D22S675, NAGT, SGLT1"	ENSG00000100170	"Solute carrier family 5 member 1"	P13866	22	32043032-32113029	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"intestine: 274.9"	"Cell line enhanced"	"Detected in some"		"CACO-2: 6.3;NB-4: 2.4;RPMI-8226: 4.8;SCLC-21H: 1.8;SH-SY5Y: 2.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	26	"cerebellum: 8.6"	"Low region specificity"	"Detected in all"			"CAB015467, HPA051805, HPA055106"	Enhanced		Approved	Nucleoplasm,Vesicles				Vesicles	Vesicles	"CAB015467: , HPA051805: AB_2681618, HPA055106: "	"unprognostic (1.96e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.24e-2)"	"prognostic favourable (2.59e-4)"	"unprognostic (3.85e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.60e-2)"	"unprognostic (2.15e-1)"	"unprognostic (9.22e-2)"	"unprognostic (4.83e-2)"	"unprognostic (6.21e-2)"	"unprognostic (9.53e-2)"	"prognostic favourable (6.97e-7)"	"unprognostic (4.68e-3)"	"unprognostic (1.98e-1)"	"unprognostic (6.00e-2)"	"unprognostic (1.45e-2)"	0.2	0.0	0.2	1.3	0.2	0.0	1.5	0.2	0.2	2.2	181.5	0.2	2.9	95.5	0.3	0.8	1.9	0.0	14.1	24.5	0.2	0.0	1.0	0.9	0.3	0.2	0.2	0.2	0.2	0.4	0.0	1.0	0.2	0.2	0.8	1.6	0.2	5.7	3.5	0.2	4.6	274.9	0.2	0.2	0.7	1.2	0.8	0.2	0.2	0.2	3.5	1.5	0.2	2.0	0.3	0.1	0.6	0.8	0.3	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	1.6	0.0	0.0	0.0	0.0	6.3	1.3	0.0	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.3	0.0	0.1	0.0	2.4	0.1	0.0	0.0	0.0	4.8	0.0	0.1	1.8	2.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.2	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.2	0.6	0.3	0.8	0.1	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2
SLC5A9	SGLT4	ENSG00000117834	"Solute carrier family 5 member 9"	Q2M3M2	1	48222685-48248644	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"intestine: 77.3"	"Cell line enriched"	"Detected in some"	8	"Hep G2: 17.8"	"Cancer enhanced"	"Detected in many"		"liver cancer: 4.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA050263			Approved	"Actin filaments,Cytosol"				"Actin filaments"	"Actin filaments"	"HPA050263: "	"unprognostic (3.09e-3)"	"unprognostic (1.89e-1)"	"unprognostic (6.75e-2)"	"unprognostic (5.66e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.35e-3)"	"unprognostic (3.64e-2)"	"unprognostic (4.59e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.59e-1)"	"unprognostic (7.42e-2)"	"unprognostic (1.97e-1)"	"prognostic unfavourable (1.84e-5)"	"unprognostic (4.56e-1)"	"unprognostic (2.11e-1)"	"unprognostic (4.30e-3)"	"unprognostic (1.06e-2)"	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	33.0	0.1	0.8	26.0	0.1	7.2	0.1	0.2	2.2	0.1	0.0	0.0	3.1	4.9	2.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.4	0.0	1.0	77.3	0.0	0.0	0.0	0.4	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.4	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	17.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CDH17	"cadherin, HPT-1"	ENSG00000079112	"Cadherin 17"	Q12864	8	94127171-94217303	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"intestine: 184.4"	"Group enriched"	"Detected in some"	7	"CACO-2: 33.3;U-266/70: 55.3"	"Group enriched"	"Detected in many"	6	"colorectal cancer: 156.4;stomach cancer: 54.9"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in many"	5	"neutrophil: 12.1"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 12.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA023614, HPA023616, CAB025143, HPA026556"	Enhanced		Enhanced	"Nucleoplasm,Cell Junctions"		3400000	3400000	"Cell Junctions"	"Cell Junctions"	"CAB025143: , HPA023614: AB_1845896, HPA023616: AB_1845895, HPA026556: AB_1845897"	"unprognostic (2.08e-1)"	"unprognostic (5.00e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.02e-1)"	"unprognostic (3.06e-2)"	"unprognostic (5.60e-2)"	"unprognostic (3.38e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.74e-1)"	"unprognostic (5.47e-2)"	"unprognostic (3.74e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.31e-1)"	"unprognostic (7.33e-2)"	"unprognostic (1.46e-2)"	0.3	0.2	0.2	17.6	0.3	0.3	0.3	0.2	0.2	0.3	88.9	0.2	0.2	54.5	0.4	0.3	0.4	0.4	7.0	0.6	0.2	0.3	0.3	0.3	0.3	0.5	0.2	0.2	0.3	0.4	0.0	0.3	0.2	0.2	0.4	44.0	0.2	0.3	0.2	0.3	0.2	184.4	1.4	0.2	0.6	0.3	0.3	0.2	0.3	0.2	0.2	0.5	0.4	0.3	1.5	0.8	12.1	1.0	1.4	0.6	0.1	0.1	6.1	0.3	0.4	0.0	0.1	0.5	0.1	0.1	0.0	0.1	33.3	1.5	0.2	0.1	0.0	0.4	0.1	0.1	0.1	0.1	0.5	0.1	0.6	0.2	0.1	0.1	1.7	0.0	0.0	0.1	0.0	0.0	0.2	0.7	0.0	0.4	0.2	0.5	0.2	0.2	0.4	0.1	1.0	0.1	0.1	0.6	0.4	0.2	0.2	0.2	0.3	0.3	0.2	0.3	0.3	0.5	0.2	55.3	0.1	0.1	0.1	0.2	0.3	2.5	1.0	1.2	0.5	0.8	0.3	0.6	0.5	0.4	0.8	1.5	0.5	0.6	12.1	1.4	0.5	0.7	0.5	0.1	0.2	0.3	0.2	0.2	0.2	0.3	0.2	0.2	0.2	0.2
GNAT3	"GDCA, gustducin"	ENSG00000214415	"G protein subunit alpha transducin 3"	A8MTJ3	7	80458671-80512020	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"intestine: 14.5"	"Cell line enriched"	"Detected in some"	6	"SCLC-21H: 8.6"	"Group enriched"	"Detected in some"	6	"breast cancer: 0.8;urothelial cancer: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	17	"olfactory region: 1.8"																						"unprognostic (2.01e-1)"							1.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	6.8	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	14.5	0.0	0.0	0.0	0.1	1.1	0.0	0.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.0	0.1	0.1	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0
MYO15B	MYO15BP	ENSG00000266714	"Myosin XVB"		17	75588058-75626501	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in all"	10	"intestine: 155.3"	"Cell line enhanced"	"Detected in many"		"A549: 25.6;HEL: 10.7;HMC-1: 14.7;THP-1: 21.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"							"HPA022857, HPA023105"			Approved	Cytosol				Cytosol	Cytosol	"HPA022857: , HPA023105: "	"prognostic favourable (9.34e-4)"	"unprognostic (7.55e-2)"	"unprognostic (6.99e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.12e-1)"	"unprognostic (5.59e-4)"	"unprognostic (7.29e-3)"	"unprognostic (1.48e-1)"	"unprognostic (4.97e-2)"	"unprognostic (2.28e-1)"	"unprognostic (8.54e-3)"	"unprognostic (1.04e-2)"	"unprognostic (1.49e-1)"	"unprognostic (6.39e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.35e-1)"	"prognostic favourable (6.90e-5)"	7.5	2.8	4.2	7.3	5.3	13.8	8.9	1.6	4.3	8.0	58.9	8.1	5.4	48.9	13.6	4.5	2.8	10.8	13.5	5.8	4.5	1.7	13.0	2.0	10.7	5.0	6.5	5.5	14.9	3.6	1.8	3.7	4.0	5.1	7.1	5.9	6.5	5.2	4.5	3.1	3.9	155.3	5.9	4.0	13.2	4.8	3.1	5.9	5.5	14.0	2.3	4.0	4.9	7.2	2.8	2.0	6.2	1.5	1.9	1.4	1.1	0.3	25.6	0.3	0.9	0.2	0.4	0.3	0.1	0.0	0.0	0.0	3.3	7.3	0.3	1.0	0.0	0.4	0.0	0.0	0.0	0.3	1.9	10.7	4.9	6.3	0.7	0.0	14.7	0.7	0.4	0.0	0.0	0.1	0.6	2.8	0.0	3.5	0.2	4.2	0.5	6.4	6.6	0.2	1.1	0.1	0.5	1.0	2.0	0.2	0.4	0.8	2.2	21.1	0.5	0.1	1.1	0.1	0.1	1.4	0.8	0.1	0.6	5.2	0.4	2.4	1.5	1.2	1.4	1.4	0.9	1.5	0.7	0.5	0.8	2.8	0.5	1.0	6.2	1.9	1.5	2.0	0.2	1.1	4.2	5.3	1.6	4.3	4.5	1.7	6.5	5.5	5.1	5.9
RETNLB	"FIZZ2, HXCP2, RELMb"	ENSG00000163515	"Resistin like beta"	Q9BQ08	3	108743424-108757384	"Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	10	"intestine: 71.9"	"Cell line enhanced"	"Detected in single"		"RPMI-8226: 1.6"	"Cancer enriched"	"Detected in some"	10	"colorectal cancer: 16.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA049152	Approved				"Secreted to blood"					"HPA049152: AB_2680655"			"prognostic favourable (6.86e-5)"			"unprognostic (1.19e-3)"		"unprognostic (3.37e-2)"		"unprognostic (4.69e-2)"				"unprognostic (2.67e-2)"	"unprognostic (5.78e-2)"		"unprognostic (4.26e-1)"	0.1	0.0	0.1	7.0	0.1	0.0	0.1	0.1	0.1	0.1	20.6	0.1	0.1	4.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.2	71.9	0.1	0.1	0.1	0.1	0.0	24.1	0.1	0.1	0.1	0.1	0.2	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
SLC2A7	GLUT7	ENSG00000197241	"Solute carrier family 2 member 7"	Q6PXP3	1	9003300-9026345	"Predicted membrane proteins, Transporters"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	10	"intestine: 19.3"	"Cell line enhanced"	"Detected in single"		"Daudi: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 1.0"	"Lineage enriched"	"Detected in single"	10	"T-cells: 1.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA039931	Uncertain									"HPA039931: AB_10671046"	"unprognostic (4.19e-2)"	"unprognostic (3.68e-1)"				"unprognostic (1.96e-2)"		"unprognostic (2.20e-1)"		"unprognostic (1.05e-2)"	"unprognostic (3.43e-1)"	"unprognostic (9.05e-2)"	"unprognostic (5.69e-4)"	"unprognostic (5.09e-2)"	"unprognostic (7.12e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.35e-1)"	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	7.6	0.0	0.0	7.2	0.0	0.7	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	19.3	0.0	0.0	0.0	0.1	1.8	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.7	0.0	1.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.3	0.4	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TUBAL3	FLJ21665	ENSG00000178462	"Tubulin alpha like 3"	A6NHL2	10	5393098-5404830	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"intestine: 41.5"	"Group enriched"	"Detected in some"	6	"HEL: 16.5;K-562: 5.2"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 3.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA045900, HPA063394"	Uncertain									"HPA045900: AB_10961130, HPA063394: AB_2685003"	"unprognostic (2.63e-1)"	"unprognostic (1.69e-2)"	"unprognostic (5.33e-2)"	"unprognostic (1.09e-1)"	"unprognostic (7.59e-2)"	"unprognostic (2.13e-2)"		"unprognostic (3.02e-2)"	"unprognostic (4.02e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.44e-1)"	"unprognostic (4.52e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.35e-4)"	"unprognostic (7.93e-4)"	0.2	0.0	0.3	0.7	0.4	0.0	0.2	0.1	0.9	0.1	16.1	0.1	0.1	18.0	0.4	0.1	0.3	0.1	0.3	0.5	0.2	0.2	4.1	0.1	0.1	0.1	0.2	0.1	0.2	0.1	0.0	0.1	0.1	0.7	0.2	8.1	0.1	0.8	0.1	0.1	0.4	41.5	0.1	0.4	0.1	0.1	1.2	0.2	0.1	0.1	1.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.7	0.9	0.0	1.6	0.0	0.4	0.0	0.9	0.0	0.0	0.0	16.5	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	5.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.4	0.1	0.9	0.2	0.2	0.2	0.1	0.7	0.2
AC004754.1		ENSG00000269881			16	249547-269943	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in some"	9	"intestine: 15.3"	"Cell line enhanced"	"Detected in some"		"ASC diff: 2.5;ASC TERT1: 2.4;EFO-21: 5.1;HHSteC: 2.5"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"naive CD4 T-cell: 1.5"	"Low lineage specificity"	"Detected in single"											"HPA011651, HPA071871"	Uncertain		Uncertain	Nucleoplasm,Mitochondria				Mitochondria	Mitochondria	"HPA011651: , HPA071871: AB_2732188"	"unprognostic (1.22e-1)"	"unprognostic (2.09e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.75e-2)"	"unprognostic (5.40e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.32e-1)"	"unprognostic (3.37e-2)"	"unprognostic (5.06e-2)"	"unprognostic (5.24e-3)"	"unprognostic (4.66e-2)"	"unprognostic (7.84e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.95e-2)"	0.5	0.0	0.7	0.0	1.1	0.0	0.0	0.3	0.6	0.6	0.2			15.3	0.3	0.3	0.1	0.2	0.0	0.9	0.4	1.4	0.3	0.1	0.0	0.0	0.7		0.1	1.7	0.0	0.2	0.0		0.2	0.0		0.0	0.3	1.0	0.1	7.4	0.2	0.7	0.0	0.1	0.9			0.1		0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.4	1.5	0.0	0.0	0.8	0.4	1.8	2.5	2.4	0.5	0.0	1.2	0.0	0.1	0.3	0.1	0.0	5.1	1.1	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	2.5	0.0	0.0	1.0	0.0	0.2	1.0	0.7	0.0	0.3	0.0	2.2	0.0	0.2	1.2	0.0	1.3	0.0	0.0	0.9	0.0	0.3	1.0	0.0	0.0	0.4	1.0	0.6	0.0	0.4	0.0	1.0	0.0	0.1	0.2	0.1	0.2	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.7	0.8	0.0	0.5	1.5	0.4	0.0	0.4	0.0	0.0	0.0	0.0										
BCL2L15	"Bfk, C1orf178, FLJ22588"	ENSG00000188761	"BCL2 like 15"	Q5TBC7	1	113878168-113887547	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"intestine: 84.0"	"Group enriched"	"Detected in some"	4	"CAPAN-2: 22.6;EFO-21: 7.8;RPTEC TERT1: 6.7"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 10.5"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 1.6;neutrophil: 1.9"	"Group enriched"	"Detected in many"	6	"granulocytes: 1.9;T-cells: 1.6"	"Region enriched"	"Detected in single"	32	"cerebellum: 36.9"	"Low region specificity"	"Detected in all"			"HPA029732, HPA029733"	Enhanced									"HPA029732: AB_10599615, HPA029733: AB_10600422"	"unprognostic (5.96e-2)"	"unprognostic (6.41e-3)"	"unprognostic (5.82e-2)"	"prognostic favourable (5.63e-4)"	"unprognostic (2.16e-1)"	"unprognostic (6.23e-3)"	"unprognostic (4.97e-4)"	"unprognostic (1.74e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.42e-7)"	"unprognostic (5.20e-2)"	"unprognostic (2.24e-2)"	"unprognostic (9.04e-3)"	"unprognostic (4.27e-2)"	0.4	0.2	0.4	3.8	0.4	5.7	0.4	0.9	0.4	2.6	30.5	0.4	0.7	25.4	0.6	2.4	2.3	0.5	4.9	0.4	0.4	0.2	1.3	0.4	0.7	0.4	0.4	0.4	0.6	9.4	0.0	0.4	0.4	0.4	0.5	18.8	0.4	0.4	0.4	0.4	0.2	84.0	0.4	0.4	0.5	9.4	0.6	0.4	0.4	0.4	0.9	0.6	0.8	0.6	0.0	0.0	1.9	0.3	0.0	1.6	0.4	0.0	2.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.6	0.1	7.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.4	0.0	2.1	0.3	0.2	0.0	0.0	0.0	0.3	0.5	6.7	0.0	0.1	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.2	0.4	0.1	0.8	0.1	0.0	0.0	0.0	0.0	0.1	0.0	1.6	0.0	1.2	0.5	0.0	0.0	0.2	0.0	1.9	0.0	0.3	0.0	0.0	0.4	0.4	0.4	0.9	0.4	0.4	0.2	0.4	0.4	0.4	0.4
DGAT1	"ARGP1, DGAT"	ENSG00000185000	"Diacylglycerol O-acyltransferase 1"	O75907	8	144314584-144326910	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	9	"intestine: 161.0"	"Cell line enhanced"	"Detected in many"		"Hep G2: 15.8;PC-3: 17.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB032853	Enhanced		Approved	"Nucleoli,Endoplasmic reticulum"				"Endoplasmic reticulum"	"Endoplasmic reticulum"	"CAB032853: AB_2090798"	"unprognostic (9.24e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.49e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.42e-2)"	"unprognostic (5.10e-2)"	"unprognostic (2.78e-2)"	"unprognostic (6.88e-2)"	"unprognostic (3.52e-1)"	"unprognostic (2.65e-3)"	"unprognostic (3.83e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.67e-3)"	11.8	18.5	3.6	5.7	4.7	6.4	6.8	6.6	5.6	3.3	60.2	4.0	6.4	44.7	3.9	3.6	5.5	3.1	7.9	6.3	3.7	2.7	6.7	14.4	3.8	3.1	4.1	2.7	3.3	3.9	5.0	4.0	4.3	3.6	3.4	6.3	4.1	5.9	4.3	10.0	4.8	161.0	3.6	2.6	5.3	5.7	10.7	4.2	5.1	3.8	6.2	5.0	4.7	3.4	0.7	2.2	2.8	2.0	0.3	1.7	0.8	3.8	4.1	1.9	3.6	3.2	1.3	2.3	2.7	2.7	2.6	1.8	9.7	2.6	1.5	10.6	1.7	3.3	1.6	3.7	0.5	2.8	4.0	2.8	3.3	15.8	2.3	0.7	2.9	1.8	2.9	1.6	1.9	2.0	2.2	3.5	1.7	3.2	4.8	3.1	0.9	17.6	6.2	0.8	2.5	2.4	2.1	2.0	3.4	3.6	4.4	1.8	2.5	2.7	1.6	1.4	4.9	2.8	2.2	2.0	0.4	0.6	1.4	4.9	2.3	0.0	2.0	2.8	1.2	1.3	1.7	0.7	0.9	1.1	2.2	0.5	0.7	0.3	2.3	0.3	1.7	1.1	0.7	0.8	3.6	4.7	6.6	5.6	3.7	2.7	4.1	2.7	3.6	4.2
PYY	PYY1	ENSG00000131096	"Peptide YY"	P10082	17	43952738-44004469	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"intestine: 40.0"	"Cell line enhanced"	"Detected in many"		"HMC-1: 7.8"	"Group enriched"	"Detected in many"	8	"endometrial cancer: 7.9;ovarian cancer: 15.2;testis cancer: 18.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	22	"pons and medulla: 1.4"	"Low region specificity"	"Detected in many"			"HPA010973, CAB016734"	Enhanced				"Secreted to blood"					"CAB016734: AB_876471, HPA010973: AB_1855194"	"unprognostic (8.17e-3)"	"unprognostic (5.41e-2)"	"unprognostic (9.93e-2)"	"unprognostic (1.81e-3)"	"unprognostic (2.48e-4)"	"unprognostic (5.26e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.54e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.69e-3)"	"unprognostic (3.77e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.20e-1)"	0.1	0.8	0.1	2.0	0.2	0.0	0.2	0.1	0.1	0.1	40.0	0.1	0.1	1.2	0.2	0.1	0.1	0.2	0.1	0.1	0.1	0.2	0.6	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.0	0.1	0.1	0.5	0.1	20.6	0.1	0.1	0.3	0.1	0.0	24.8	0.1	0.1	0.1	0.1	1.0	0.1	4.2	0.2	0.1	0.1	0.1	0.1	0.9	0.1	0.0	0.1	0.0	0.4	0.0	0.2	0.5	0.7	1.2	1.0	1.7	0.2	1.2	0.3	1.4	0.8	1.2	0.9	0.7	1.6	1.4	0.7	1.1	0.4	0.9	3.1	0.6	1.8	0.5	0.2	1.2	0.5	7.8	2.2	0.4	1.3	0.6	0.3	0.4	1.3	1.2	1.6	0.5	1.0	1.5	0.7	0.3	0.3	0.2	2.1	0.1	1.3	0.3	0.7	0.0	2.0	1.2	0.1	1.3	1.5	1.4	0.3	1.1	0.1	1.2	0.2	1.8	0.1	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.1	0.1	0.2	0.1	0.1	0.5	0.1
SLC39A4	"AEZ, AWMS2, ZIP4"	ENSG00000147804	"Solute carrier family 39 member 4"	Q6P5W5	8	144409742-144416895	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"intestine: 77.7"	"Group enriched"	"Detected in some"	11	"CAPAN-2: 17.3;Hep G2: 44.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"														"unprognostic (2.59e-1)"	"unprognostic (2.35e-3)"	"unprognostic (9.16e-2)"	"unprognostic (3.84e-2)"	"unprognostic (5.63e-3)"	"unprognostic (1.46e-1)"	"unprognostic (5.40e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.28e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.24e-1)"	"prognostic favourable (9.04e-4)"	"unprognostic (2.78e-2)"	"unprognostic (3.97e-1)"	"unprognostic (9.04e-3)"	"unprognostic (1.87e-1)"	0.2	0.0	0.5	1.1	0.2	0.1	0.2	0.2	1.1	0.2	73.9	0.2	0.2	42.1	0.2	0.4	0.2	0.3	0.7	0.2	0.2	0.0	8.3	0.4	1.3	0.2	0.2	0.2	1.5	0.6	0.0	0.3	0.4	0.2	0.4	0.1	0.2	0.5	0.2	0.2	0.0	77.7	0.2	0.2	0.2	1.2	0.4	0.2	0.2	2.3	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.0	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	1.1	17.3	0.0	0.5	0.0	0.1	0.0	0.0	0.0	2.9	0.4	0.7	0.1	44.2	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.7	1.0	0.0	0.7	0.0	0.1	0.0	0.0	0.2	0.0	0.5	0.0	0.2	0.4	0.9	0.0	0.2	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.2	0.2	1.1	0.2	0.0	0.2	0.2	0.2	0.2
AQP10		ENSG00000143595	"Aquaporin 10"	Q96PS8	1	154321090-154325325	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	8	"intestine: 59.9"	"Cell line enhanced"	"Detected in some"		"HEL: 15.6;HMC-1: 6.5;K-562: 17.9;SH-SY5Y: 4.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in many"			"HPA062621, HPA065947"	Enhanced		Approved	"Nuclear bodies,Vesicles,Plasma membrane"				"Nuclear bodies, Vesicles, Plasma membrane"	"Nuclear bodies, Vesicles, Plasma membrane"	"HPA062621: , HPA065947: AB_2685584"	"unprognostic (6.84e-2)"	"unprognostic (4.97e-2)"		"unprognostic (4.19e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.09e-1)"	"unprognostic (8.45e-4)"	"unprognostic (1.63e-1)"	"unprognostic (3.07e-1)"	"unprognostic (4.08e-2)"	"unprognostic (3.99e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.68e-1)"		"unprognostic (7.64e-3)"	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	36.0	0.0	0.0	37.2	0.2	0.3	0.1	4.3	0.5	0.7	0.4	0.0	0.0	0.1	2.2	0.4	0.1	0.0	0.4	0.1	0.0	0.0	0.2	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.3	59.9	0.0	0.0	2.7	0.3	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.9	0.1	0.0	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	15.6	0.0	0.0	0.0	0.0	6.5	0.0	0.1	0.0	0.0	0.0	17.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	7.6	0.0	0.2	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0
C6orf222	DKFZp779B1540	ENSG00000189325	"Chromosome 6 open reading frame 222"	P0C671	6	36315757-36336885	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"intestine: 46.7"	"Group enriched"	"Detected in some"	4	"CACO-2: 3.1;Daudi: 3.4;REH: 3.3;RT4: 1.6;U-937: 3.6"	"Group enriched"	"Detected in some"	19	"colorectal cancer: 8.7;pancreatic cancer: 5.1;stomach cancer: 8.5"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.3"	"Low lineage specificity"	"Detected in single"							"Low region specificity"	"Detected in all"			"HPA038407, HPA058189"	Uncertain									"HPA038407: AB_10669644, HPA058189: AB_2683634"	"unprognostic (1.97e-5)"	"unprognostic (5.46e-3)"	"unprognostic (3.93e-1)"	"unprognostic (1.49e-1)"	"unprognostic (7.52e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.81e-1)"	"unprognostic (4.13e-1)"		"unprognostic (1.22e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.75e-2)"	"unprognostic (3.04e-2)"	"unprognostic (4.55e-2)"	"unprognostic (3.16e-2)"	"unprognostic (3.98e-1)"	"unprognostic (1.66e-4)"	0.1	0.0	0.1	0.7	0.1	0.0	0.1	0.1	0.2	0.1	14.0	0.1	0.1	19.8	0.1	0.1	0.1	0.0	1.2	0.1	0.1	0.1	0.3	0.1	0.2	0.1	0.1	0.1	0.1	4.7	0.0	0.1	0.1	0.1	0.1	4.6	0.1	0.1	0.1	0.1	0.2	46.7	0.1	0.1	0.1	5.8	1.4	0.1	0.3	0.1	0.1	0.1	0.1	0.1	1.3	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.1	3.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.6	0.0	1.6	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	1.3	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1
ERICH4	"C19orf69, LOC100170765"	ENSG00000204978	"Glutamate rich 4"	A6NGS2	19	41443158-41444765	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"intestine: 78.1"	"Group enriched"	"Detected in some"	12	"CACO-2: 4.7;Hep G2: 10.8;THP-1: 3.0"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA042632, HPA048484"	Uncertain		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA042632: AB_2678090, HPA048484: AB_2680415"	"unprognostic (1.41e-1)"	"unprognostic (3.05e-1)"	"unprognostic (9.52e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.76e-1)"		"unprognostic (4.03e-5)"	"unprognostic (8.53e-2)"		"unprognostic (7.54e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.79e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.16e-1)"		0.6	0.0	0.2	0.2	0.3	0.0	0.6	0.2	0.3	0.4	21.0	0.2	0.2	27.1	0.4	0.4	0.2	0.4	0.5	1.3	0.2	0.0	10.0	0.2	1.2	0.2	0.3	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.9	0.0	78.1	0.2	0.3	0.2	0.1	0.8	0.2	0.2	0.3	0.2	0.2	0.3	0.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	10.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	3.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.3	0.2	0.3	0.2	0.0	0.3	0.2	0.2	0.2
SLC15A1	"HPECT1, HPEPT1, PEPT1"	ENSG00000088386	"Solute carrier family 15 member 1"	P46059	13	98683801-98752654	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"intestine: 134.9"	"Group enriched"	"Detected in some"	6	"CAPAN-2: 29.5;SK-BR-3: 29.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA002827	Uncertain		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA002827: AB_1856974"	"unprognostic (8.76e-2)"	"unprognostic (1.87e-1)"	"unprognostic (4.72e-2)"	"unprognostic (1.49e-1)"	"unprognostic (6.76e-3)"	"unprognostic (6.26e-2)"	"unprognostic (7.83e-2)"	"unprognostic (5.47e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.37e-1)"	"unprognostic (6.79e-2)"	"unprognostic (6.88e-4)"	"unprognostic (2.11e-2)"	"unprognostic (2.84e-1)"	"unprognostic (2.64e-1)"	"unprognostic (9.01e-2)"	"unprognostic (3.87e-2)"	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	1.1	51.7	0.2	0.3	42.7	1.9	2.2	0.9	0.1	16.6	0.1	0.1	0.1	6.3	8.2	0.2	0.1	0.1	0.1	0.2	7.1	4.3	0.3	1.0	0.3	0.9	0.5	0.2	0.3	0.3	0.1	9.9	134.9	0.1	0.1	0.1	0.2	0.2	0.1	0.3	0.2	0.7	0.4	0.5	1.9	1.1	1.1	2.3	0.7	1.2	0.9	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	4.8	29.5	0.0	1.2	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	1.6	1.7	0.6	0.1	0.3	0.0	29.4	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.7	0.7	0.9	0.3	0.8	0.8	0.7	0.7	0.2	1.1	0.9	0.8	2.2	1.2	0.4	1.1	0.6	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.1
SSUH2	"C3orf32, fls485, ssu-2"	ENSG00000125046	"Ssu-2 homolog (C. elegans)"	Q9Y2M2	3	8619400-8745040	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	8	"intestine: 45.1"	"Cell line enriched"	"Detected in some"	20	"Hep G2: 23.9"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA049777	Approved									"HPA049777: AB_2680876"	"unprognostic (2.49e-1)"	"unprognostic (7.62e-2)"	"unprognostic (9.65e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.46e-1)"	"unprognostic (8.86e-2)"	"unprognostic (1.46e-3)"	"unprognostic (9.79e-2)"	"unprognostic (1.53e-1)"	"unprognostic (4.09e-1)"	"unprognostic (7.97e-3)"	"unprognostic (1.52e-1)"	"unprognostic (3.15e-3)"	"unprognostic (1.31e-1)"	"unprognostic (3.65e-2)"	"unprognostic (4.96e-2)"	"unprognostic (7.50e-2)"	0.7	0.3	0.3	0.4	0.6	0.0	0.6	0.3	0.4	0.7	37.3	0.3	0.2	8.5	1.0	0.2	0.3	0.7	1.4	2.8	0.3	0.3	1.1	0.5	0.2	0.2	0.2	0.3	0.3	0.2	0.0	0.3	0.5	0.5	0.4	0.3	0.3	1.7	0.2	0.3	0.2	45.1	0.8	0.2	2.0	0.4	5.6	0.2	0.2	1.1	1.5	0.5	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.1	23.9	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.3	0.4	0.3	0.3	0.2	0.3	0.5	0.2
TREH	"MGC129621, TRE, TREA"	ENSG00000118094	Trehalase	O43280	11	118657316-118679690	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"intestine: 51.8"	"Cell line enhanced"	"Detected in some"		"BEWO: 5.3;Hep G2: 2.1;RPMI-8226: 1.9;SiHa: 1.8;U-2 OS: 2.5"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA039913, HPA042045"	Enhanced				"Intracellular and membrane"	12000000	12000000			"HPA039913: AB_10674988, HPA042045: AB_2677817"	"unprognostic (1.29e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.01e-2)"	"unprognostic (5.22e-4)"	"unprognostic (2.52e-1)"	"unprognostic (9.83e-2)"	"prognostic favourable (3.76e-4)"	"unprognostic (1.17e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.63e-2)"	"prognostic favourable (2.33e-6)"	"unprognostic (2.09e-2)"	"unprognostic (6.30e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.15e-1)"	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.2	0.1	0.1	24.1	0.0	0.0	28.9	0.1	3.3	0.6	0.1	3.7	0.1	0.1	0.1	6.1	2.6	0.1	0.0	0.1	0.0	0.1	0.5	0.0	0.1	0.0	0.1	0.2	0.4	0.0	0.2	0.0	0.1	0.1	51.8	0.0	0.1	0.1	0.6	0.3	0.0	0.0	0.1	0.0	0.3	0.1	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.3	5.3	0.0	0.0	0.0	0.0	0.8	0.7	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.1	1.9	0.0	0.0	0.2	0.9	1.8	0.2	1.4	0.7	0.0	0.8	0.1	2.5	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.0
CDHR2	"FLJ20124, FLJ20383, PC-LKC, PCDH24, PCLKC"	ENSG00000074276	"Cadherin related family member 2"	Q9BYE9	5	176542511-176595974	"Plasma proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"intestine: 179.8"	"Cell line enriched"	"Detected in some"	14	"Hep G2: 21.7"	"Group enriched"	"Detected in many"	14	"colorectal cancer: 9.1;liver cancer: 5.7;pancreatic cancer: 11.7;renal cancer: 8.6;stomach cancer: 9.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	6	"hypothalamus: 2.5"	"Low region specificity"	"Detected in many"			"HPA012569, HPA017053"	Enhanced					3600000	3600000			"HPA012569: AB_1845298, HPA017053: AB_1845297"	"unprognostic (1.34e-2)"	"unprognostic (8.90e-4)"	"unprognostic (3.82e-2)"	"unprognostic (8.51e-2)"	"unprognostic (5.10e-4)"	"unprognostic (4.24e-3)"	"unprognostic (6.66e-2)"	"unprognostic (2.06e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.99e-1)"	"unprognostic (7.66e-3)"	"unprognostic (1.75e-1)"	"prognostic favourable (9.29e-4)"	"unprognostic (6.58e-2)"	"unprognostic (3.55e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.42e-1)"	0.1	0.0	0.1	2.5	0.3	0.0	0.1	0.1	0.3	0.1	80.0	0.1	0.1	67.2	0.1	0.8	0.1	0.2	7.1	0.1	0.1	0.4	3.0	26.6	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.1	2.9	0.5	0.1	0.1	0.1	0.1	179.8	0.1	0.1	0.1	2.8	1.6	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.8	0.3	0.0	0.1	0.1	0.0	0.2	0.3	0.5	0.0	0.0	0.7	0.0	0.0	0.0	0.0	1.0	0.2	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	21.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.1	0.5	0.0	0.0	0.1	0.0	1.5	0.0	0.0	0.3	1.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.3	0.0	0.0	0.1	0.1	0.3	0.1	0.3	0.1	0.4	0.1	0.1	0.1	0.1
CDHR5	"FLJ20219, MU-PCDH, MUCDHL, MUPCDH"	ENSG00000099834	"Cadherin related family member 5"	Q9HBB8	11	616565-626078	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"intestine: 296.7"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.4;CACO-2: 6.6;RPMI-8226: 3.7"	"Group enriched"	"Detected in many"	17	"colorectal cancer: 33.2;liver cancer: 61.6;pancreatic cancer: 12.7;renal cancer: 35.4;stomach cancer: 26.7"	"Region enriched"	"Detected in single"	7	"pons and medulla: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA009081, HPA009173, CAB025004"	Enhanced				"Intracellular and membrane"	170000000	170000000			"CAB025004: , HPA009081: AB_1079428, HPA009173: AB_1079429"	"unprognostic (7.65e-2)"	"unprognostic (1.42e-1)"	"unprognostic (9.85e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.05e-1)"	"unprognostic (5.56e-3)"	"unprognostic (4.89e-2)"	"unprognostic (3.85e-2)"	"unprognostic (5.75e-2)"	"unprognostic (6.36e-2)"	"unprognostic (7.95e-2)"	"unprognostic (5.07e-2)"	"unprognostic (5.01e-2)"	"unprognostic (3.90e-1)"	"unprognostic (8.85e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.14e-2)"	0.1	0.3	0.1	8.1	0.1	0.0	0.1	0.1	0.1	0.1	118.7	0.4	0.0	34.3	0.1	0.8	0.1	0.2	12.1	0.1	0.2	0.1	10.9	43.8	0.1	0.0	0.1	0.0	0.1	0.5	0.0	0.2	0.0	1.6	0.1	21.3	5.1	0.1	0.0	0.1	0.1	296.7	0.8	0.1	0.1	1.1	0.2	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.6	0.0	0.0	2.4	0.0	0.0	0.0	0.0	6.6	0.3	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.3	1.5	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.5	0.1	0.7	0.8	0.0	0.1	0.1	3.7	0.0	0.3	0.0	1.6	0.0	0.2	0.0	0.0	0.2	0.6	0.1	0.1	0.3	1.1	0.0	0.3	0.3	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.0	1.6	0.0
CPO		ENSG00000144410	"Carboxypeptidase O"	Q8IVL8	2	206939554-206969474	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"intestine: 71.1"	"Cell line enhanced"	"Detected in some"		"ASC diff: 2.9;BEWO: 1.7;hTCEpi: 2.2;NB-4: 4.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	17	"basophil: 10.3"	"Lineage enriched"	"Detected in single"	42	"granulocytes: 10.3"					"Low region specificity"	"Detected in many"								"Intracellular and membrane"						"unprognostic (9.39e-2)"	"unprognostic (2.64e-1)"	"unprognostic (2.95e-2)"	"unprognostic (5.21e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.16e-1)"	"unprognostic (9.06e-2)"	"unprognostic (4.03e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.75e-3)"	"unprognostic (1.22e-1)"	"unprognostic (3.60e-2)"	"unprognostic (2.52e-1)"	"unprognostic (6.56e-2)"	"unprognostic (4.03e-2)"	"unprognostic (4.89e-2)"	0.2	0.4	0.2	0.1	0.9	0.0	0.3	0.1	0.4	0.2	0.6	0.1	1.1	0.1	0.1	9.4	0.1	0.1	0.1	0.1	0.2	0.5	0.5	0.2	0.1	0.1	0.2	0.1	0.1	0.1	0.6	0.5	0.1	0.1	0.3	0.1	0.1	0.3	0.3	0.2	0.1	71.1	0.2	0.1	0.1	0.1	0.3	0.1	0.1	0.4	0.1	0.1	0.1	0.1	0.0	0.0	10.3	0.0	0.0	0.2	0.0	0.0	0.3	0.3	0.0	2.9	1.0	1.7	0.4	0.0	0.0	0.1	0.3	0.2	0.1	0.7	0.0	0.0	0.3	0.2	0.1	0.2	0.5	0.0	0.0	0.2	0.0	0.7	0.2	0.9	2.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	4.0	0.2	0.6	0.1	0.0	0.2	1.5	0.1	0.3	0.0	0.0	0.3	0.0	0.2	0.6	0.0	0.0	1.0	0.7	0.4	0.1	0.9	0.0	0.0	0.3	0.5	10.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.9	0.1	0.4	0.2	0.5	0.2	0.1	0.1	0.1
GIMD1		ENSG00000250298	"GIMAP family P-loop NTPase domain containing 1"	P0DJR0	4	106357485-106368825	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	7	"intestine: 24.0"	"Cell line enhanced"	"Detected in some"		"CACO-2: 1.8;HBF TERT88: 1.0;HEL: 1.0;NB-4: 1.2;U-138 MG: 1.4"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"																															0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	0.0	0.0	23.5	0.0	0.0	0.0	0.0	3.5	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.9	1.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
LRRC66		ENSG00000188993	"Leucine rich repeat containing 66"	Q68CR7	4	51993702-52017620	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"intestine: 50.2"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 4.5;CAPAN-2: 5.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			"HPA014549, HPA027839"	Uncertain									"HPA014549: AB_1853062, HPA027839: AB_10602705"	"unprognostic (1.10e-1)"	"unprognostic (4.87e-2)"	"unprognostic (8.62e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.57e-2)"	"unprognostic (4.83e-3)"	"unprognostic (2.93e-1)"	"unprognostic (4.09e-3)"	"unprognostic (1.61e-2)"	"unprognostic (1.89e-1)"	"unprognostic (6.31e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.05e-1)"	"unprognostic (4.06e-1)"	0.5	0.1	0.8	2.6	1.0	0.0	0.5	1.4	0.9	0.5	11.3	0.5	0.5	19.6	0.5	0.5	0.5	0.5	1.6	0.6	0.8	0.8	0.9	0.5	0.5	0.5	0.8	0.5	0.5	0.5	0.5	3.1	0.5	0.5	0.5	5.2	0.5	0.5	0.5	6.7	0.0	50.2	0.5	0.6	0.5	4.6	0.7	0.5	0.5	0.5	0.5	0.5	0.5	0.5	0.2	0.0	0.0	0.1	0.0	0.6	0.0	0.1	0.2	0.4	0.7	1.9	4.5	0.2	0.7	1.1	0.4	0.8	0.2	5.7	0.0	0.1	1.1	0.0	0.3	0.3	0.3	1.8	0.7	0.0	0.2	0.0	0.2	0.1	0.1	1.7	1.0	0.9	0.3	0.4	0.0	0.0	2.2	0.0	0.2	0.1	0.0	1.0	0.0	0.0	0.2	0.2	0.0	1.1	0.1	0.0	0.0	0.1	0.0	0.0	0.7	0.4	1.2	0.1	0.7	0.5	0.7	0.0	0.1	0.1	1.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.5	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.0	1.4	0.9	0.8	0.8	0.8	0.5	0.5	0.5
MUC12	MUC11	ENSG00000205277	"Mucin 12, cell surface associated"	Q9UKN1	7	100969623-101018949	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"intestine: 35.6"	"Cell line enhanced"	"Detected in single"		"NTERA-2: 1.7"	"Cancer enriched"	"Detected in some"	7	"colorectal cancer: 13.2"					"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA023835	Enhanced									"HPA023835: AB_1854199"	"unprognostic (1.38e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.84e-4)"	"unprognostic (4.40e-2)"	"unprognostic (1.30e-3)"	"unprognostic (1.84e-2)"	"unprognostic (1.40e-1)"	"unprognostic (6.52e-2)"	"unprognostic (3.72e-1)"	"unprognostic (1.92e-1)"	"unprognostic (3.33e-7)"	"unprognostic (8.42e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.52e-1)"	"unprognostic (7.54e-2)"	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	25.2			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		5.0	35.6		0.0	0.0	0.0	0.0	1.8	0.3	0.0	0.0	0.0	0.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0										
P2RY4	"NRU, P2P, P2Y4, UNR"	ENSG00000186912	"Pyrimidinergic receptor P2Y4"	P51582	X	70258170-70259764	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	7	"intestine: 14.2"	"Cell line enhanced"	"Detected in some"		"Hep G2: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB022644	Uncertain									"CAB022644: "	"unprognostic (4.59e-2)"	"unprognostic (4.23e-1)"	"unprognostic (7.10e-2)"		"unprognostic (1.69e-1)"	"unprognostic (9.53e-4)"	"unprognostic (6.53e-2)"	"unprognostic (1.82e-1)"	"unprognostic (6.77e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.09e-1)"	"unprognostic (8.89e-3)"	"unprognostic (2.90e-2)"	"unprognostic (3.72e-2)"	"unprognostic (3.61e-2)"	"unprognostic (1.50e-2)"	"unprognostic (3.89e-1)"	0.3	0.1	0.2	0.2	0.2	0.1	0.4	0.2	0.2	2.1	2.9	0.2	0.2	0.7	0.2	0.6	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.3	1.6	0.2	0.6	0.2	0.2	2.1	14.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.4	0.2	0.4	0.4	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.7	0.8	0.3	0.5	0.0	0.2	0.4	0.1	0.3	0.1	0.6	0.0	0.0	0.3	0.0	0.2	0.3	0.0	0.5	1.8	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.5	0.0	1.0	0.3	0.8	0.2	0.6	0.1	0.3	0.7	0.3	0.0	0.0	0.4	0.1	0.7	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.8	1.1	0.1	1.2	0.3	0.6	0.3	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2
PLB1	"FLJ30866, PLB"	ENSG00000163803	"Phospholipase B1"	Q6P1J6	2	28457145-28643788	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"intestine: 66.7"	"Cell line enhanced"	"Detected in some"		"AF22: 4.7;BEWO: 7.2;CACO-2: 4.7;RT4: 5.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	14	"classical monocyte: 3.1;eosinophil: 3.3;intermediate monocyte: 4.9;myeloid DC: 6.4;neutrophil: 9.9;non-classical monocyte: 5.2"	"Group enriched"	"Detected in many"	40	"dendritic cells: 6.4;granulocytes: 9.9;monocytes: 5.2"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in some"														"unprognostic (2.18e-2)"	"unprognostic (2.49e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.91e-3)"	"unprognostic (4.74e-2)"	"unprognostic (4.48e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.61e-9)"	"unprognostic (2.48e-2)"	"unprognostic (2.19e-2)"	"unprognostic (4.99e-2)"	"unprognostic (8.03e-2)"	0.9	3.3	0.7	1.0	2.1	2.9	1.0	0.6	0.7	0.9	0.8	0.6	0.6	0.2	0.8	1.7	1.3	0.7	0.9	1.4	0.6	0.9	0.8	0.6	0.7	0.6	0.8	0.6	0.6	0.6	0.0	0.7	1.3	0.7	1.0	1.1	0.7	0.6	0.9	0.9	5.2	66.7	1.7	0.8	2.8	0.5	1.2	0.6	0.6	1.2	0.9	0.6	0.9	0.6	0.0	6.4	9.9	5.2	0.0	0.1	1.1	0.8	0.1	4.7	0.1	1.0	0.7	7.2	0.2	1.9	0.5	0.4	4.7	0.5	0.5	0.5	0.7	1.0	0.0	3.8	0.4	0.3	0.1	0.4	0.7	0.8	1.6	0.8	0.3	0.8	2.2	0.7	1.2	1.2	0.0	0.1	1.3	0.0	0.0	0.6	0.2	1.0	0.0	0.8	0.0	2.1	5.3	2.1	0.4	0.2	0.3	0.4	0.0	2.5	0.5	0.5	1.4	0.2	0.2	1.0	0.2	0.0	1.7	3.6	0.1	0.0	3.1	3.3	0.0	4.9	0.0	0.0	0.1	0.0	6.4	0.0	0.0	0.0	9.9	0.0	5.2	0.3	0.1	1.1	0.7	2.1	0.6	0.7	0.6	0.9	0.8	0.6	0.7	0.6
APOA4		ENSG00000110244	"Apolipoprotein A4"	P06727	11	116820700-116823306	"Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"intestine: 593.6"	"Cell line enhanced"	"Detected in some"		"BEWO: 7.9;CACO-2: 8.0;Hep G2: 7.5;NB-4: 7.3;RPMI-8226: 11.7;SH-SY5Y: 10.8"	"Cancer enriched"	"Detected in some"	29	"liver cancer: 291.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA001352, HPA002549, CAB068250, CAB068251, CAB068252"	Enhanced		Approved	Vesicles	"Secreted to blood"	140000000000	140000000000	Vesicles	Vesicles	"CAB068250: AB_2665657, CAB068251: AB_2665659, CAB068252: , HPA001352: AB_1078179, HPA002549: AB_1078177"							"unprognostic (8.81e-2)"				"unprognostic (2.12e-2)"			"unprognostic (1.75e-2)"	"unprognostic (7.91e-2)"			0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	293.8	0.0	0.0	175.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	93.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	593.6	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	11.7	0.0	0.0	3.2	10.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CLCA1	"CaCC, CLCRG1"	ENSG00000016490	"Chloride channel accessory 1"	A8K7I4	1	86468368-86500289	"Predicted secreted proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"intestine: 242.9"	"Cell line enhanced"	"Detected in some"		"BEWO: 4.5;K-562: 1.7;NB-4: 5.2;RPMI-8226: 5.6;SH-SY5Y: 4.0;U-2197: 3.3"	"Group enriched"	"Detected in some"	9	"colorectal cancer: 86.8;pancreatic cancer: 27.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA052787, HPA059301"	Enhanced				"Secreted to digestive system"	70000	70000			"HPA052787: AB_2681947, HPA059301: AB_2683971"			"prognostic favourable (2.98e-4)"								"unprognostic (3.42e-1)"			"unprognostic (8.61e-2)"	"unprognostic (1.06e-1)"			0.2	0.2	0.2	41.7	0.2	0.0	0.2	0.2	0.2	0.2	100.0	0.1	0.1	80.7	0.2	0.1	0.2	0.3	4.4	0.2	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.1	0.2	0.2	0.0	0.2	0.1	0.1	0.2	98.0	0.2	0.2	0.1	0.2	0.2	242.9	1.1	0.2	0.2	0.2	0.3	0.1	0.1	0.2	0.2	0.1	0.2	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.6	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.1	0.1	0.1
GPA33	A33	ENSG00000143167	"Glycoprotein A33"	Q99795	1	167052836-167166479	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"intestine: 101.1"	"Cell line enhanced"	"Detected in some"		"HL-60: 1.9;MOLT-4: 2.3;NB-4: 1.1;NTERA-2: 4.0;RPMI-8226: 2.9;THP-1: 1.1"	"Cancer enriched"	"Detected in many"	6	"colorectal cancer: 84.0"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 17.8;T-reg: 13.0"	"Lineage enriched"	"Detected in many"	7	"T-cells: 17.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA018858, CAB025943"	Enhanced									"CAB025943: , HPA018858: AB_1849909"	"unprognostic (2.41e-2)"	"unprognostic (1.71e-3)"	"unprognostic (1.08e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.06e-1)"	"unprognostic (8.39e-4)"	"unprognostic (1.55e-1)"	"unprognostic (8.34e-2)"	"unprognostic (1.00e-2)"	"unprognostic (9.63e-2)"	"unprognostic (2.10e-2)"	"unprognostic (9.44e-2)"	"unprognostic (6.75e-2)"	"unprognostic (5.22e-3)"	"unprognostic (3.13e-1)"	"unprognostic (9.68e-3)"	"unprognostic (2.96e-3)"	0.2	0.2	0.2	12.1	0.2	0.0	0.2	0.2	0.2	0.2	46.9	0.2	0.1	31.6	0.2	0.1	0.3	0.2	0.3	0.2	0.2	0.2	0.2	0.2	1.2	1.6	0.2	0.1	0.2	0.2	0.0	0.2	0.3	0.2	0.2	43.5	0.2	0.3	0.1	0.2	0.2	101.1	1.4	0.2	0.6	0.2	0.2	0.1	0.6	0.2	0.1	0.6	0.2	0.2	1.7	1.7	0.1	2.5	0.1	17.8	4.6	0.0	0.0	0.2	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	1.1	4.0	0.1	0.0	0.0	2.9	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.0	2.5	1.1	0.1	7.6	3.9	1.7	1.7	17.8	2.4	0.1	0.1	1.6	0.0	13.0	4.6	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.1
HTR3E		ENSG00000186038	"5-hydroxytryptamine receptor 3E"	A5X5Y0	3	184097064-184106995	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	6	"intestine: 7.0"	"Cell line enriched"	"Detected in single"	6	"RH-30: 5.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA049764	Enhanced									"HPA049764: AB_2680869"		"unprognostic (4.12e-2)"	"unprognostic (5.86e-2)"	"unprognostic (2.15e-1)"		"unprognostic (4.57e-4)"		"unprognostic (3.61e-3)"		"unprognostic (1.15e-1)"	"unprognostic (3.16e-1)"	"unprognostic (4.47e-1)"		"unprognostic (3.32e-1)"	"unprognostic (2.67e-1)"		"unprognostic (4.16e-2)"	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.7	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
KRT20	"CK20, K20, MGC35423"	ENSG00000171431	"Keratin 20"	P35900	17	40875941-40885227	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"intestine: 232.0"	"Cell line enhanced"	"Detected in some"		"A549: 2.3;BEWO: 2.6;NB-4: 2.3;RPMI-8226: 2.8;RT4: 7.2;SH-SY5Y: 2.2"	"Group enriched"	"Detected in many"	6	"colorectal cancer: 159.5;stomach cancer: 52.7;urothelial cancer: 99.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"basal ganglia: 0.7"	"Low region specificity"	"Detected in all"			"CAB000032, HPA024309, HPA024684, HPA027236"	Enhanced		Supported	Cytosol		34000000	34000000	Cytosol	Cytosol	"CAB000032: AB_2133718, HPA024309: AB_1852220, HPA024684: AB_1852222, HPA027236: AB_1852224"	"unprognostic (3.49e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.71e-1)"	"unprognostic (6.38e-3)"	"unprognostic (5.12e-2)"	"unprognostic (2.66e-3)"	"prognostic unfavourable (7.05e-4)"	"unprognostic (2.63e-2)"			"unprognostic (4.87e-3)"	"unprognostic (2.37e-2)"	"prognostic unfavourable (1.32e-4)"	"unprognostic (5.71e-2)"	"unprognostic (6.30e-2)"		"unprognostic (7.27e-2)"	0.2	0.1	0.2	38.0	0.2	0.0	0.2	0.2	0.2	0.2	75.5	0.2	0.2	40.4	0.2	0.2	0.3	0.3	3.9	0.2	0.2	0.1	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	1.3	45.0	0.2	0.3	0.2	0.2	0.2	232.0	2.7	0.2	0.2	13.6	0.2	0.2	0.2	0.2	0.3	0.2	2.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.3	0.0	0.1	0.0	0.0	2.8	0.0	7.2	0.4	2.2	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.3	1.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2
MYO7B		ENSG00000169994	"Myosin VIIB"	Q6PIF6	2	127535802-127637729	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"intestine: 124.3"	"Cell line enriched"	"Detected in some"	18	"MOLT-4: 77.4"	"Group enriched"	"Detected in many"	8	"colorectal cancer: 17.2;pancreatic cancer: 5.4;renal cancer: 3.7;stomach cancer: 9.0"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 7.2;naive B-cell: 9.1"	"Group enriched"	"Detected in many"	24	"B-cells: 9.1;dendritic cells: 3.3;monocytes: 7.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA039131	Enhanced									"HPA039131: AB_10672771"	"unprognostic (4.10e-3)"	"unprognostic (3.81e-2)"	"unprognostic (3.80e-2)"	"unprognostic (2.23e-4)"	"unprognostic (1.14e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.07e-1)"	"unprognostic (8.51e-2)"	"unprognostic (3.76e-1)"	"unprognostic (3.86e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.03e-1)"	"prognostic favourable (1.25e-4)"	"unprognostic (2.80e-2)"	"unprognostic (8.76e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.88e-1)"	0.2	0.2	0.2	8.4	0.3	2.0	0.2	0.2	0.3	0.2	67.2	0.0	0.7	41.3	0.2	7.2	0.3	0.3	21.0	0.2	0.3	0.3	8.9	0.4	0.5	2.0	0.5	0.0	0.2	0.3	0.0	0.2	0.3	0.0	0.2	9.2	0.0	0.2	0.0	0.3	0.2	124.3	0.2	0.4	7.3	0.2	0.9	0.0	3.0	0.2	0.0	0.5	0.2	0.2	9.1	3.3	0.2	7.2	0.0	0.2	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	4.1	1.4	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	77.4	0.2	0.0	0.5	0.1	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.1	2.4	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.1	0.0	2.7	0.0	1.2	0.0	0.0	3.3	9.1	0.0	0.2	0.2	0.0	1.7	0.8	0.0	2.7	0.2	0.3	0.2	0.3	0.3	0.3	0.5	0.0	0.0	0.0
SLC51B	OSTbeta	ENSG00000186198	"Solute carrier family 51 beta subunit"	Q86UW2	15	65045370-65053396	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"intestine: 85.0"	"Group enriched"	"Detected in some"	10	"CACO-2: 16.5;EFO-21: 11.1;Hep G2: 13.8"	"Cancer enhanced"	"Detected in many"		"liver cancer: 9.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA008398, HPA008533"	Enhanced		Approved	Vesicles,Mitochondria				Mitochondria	Mitochondria	"HPA008398: , HPA008533: AB_1854824"	"unprognostic (6.18e-2)"	"unprognostic (6.75e-3)"	"unprognostic (1.66e-1)"	"unprognostic (1.31e-2)"	"unprognostic (5.88e-2)"	"unprognostic (9.49e-2)"	"unprognostic (9.77e-3)"	"unprognostic (1.81e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.76e-1)"	"unprognostic (2.24e-1)"	"unprognostic (4.34e-2)"	"prognostic favourable (8.46e-5)"	"unprognostic (5.87e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.17e-2)"	0.4	0.5	0.4	3.8	0.6	0.0	0.4	0.4	0.8	14.0	34.9	0.4	0.4	28.1	0.9	3.3	0.4	1.0	0.5	0.4	0.5	0.6	7.5	2.4	1.6	0.4	0.6	0.4	0.4	0.4	0.0	0.4	0.4	0.4	0.8	9.5	0.4	0.4	0.8	0.4	0.1	85.0	0.4	0.4	0.4	0.2	4.1	0.4	0.4	0.4	0.4	0.4	0.4	0.5	0.0	0.0	0.7	0.1	0.0	0.5	0.3	0.0	1.4	0.2	0.7	0.0	0.1	0.4	0.0	0.0	0.2	0.0	16.5	0.0	0.1	11.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	13.8	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.2	0.0	0.4	0.0	0.3	0.4	0.4	0.0	0.0	0.8	0.4	0.0	0.6	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.1	0.1	0.2	0.3	0.2	0.0	0.1	0.1	0.1	0.0	0.0	0.4	0.0	0.5	0.0	0.3	0.2	0.0	0.0	0.1	0.3	0.7	0.0	0.1	0.0	0.0	0.3	0.4	0.6	0.4	0.4	0.5	0.6	0.6	0.4	0.4	0.4
SLC6A19		ENSG00000174358	"Solute carrier family 6 member 19"	Q695T7	5	1201595-1225117	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"intestine: 167.3"	"Group enriched"	"Detected in some"	6	"BEWO: 14.2;HEL: 17.4"	"Cancer enhanced"	"Detected in many"		"renal cancer: 7.9;stomach cancer: 5.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA037415, HPA043207"	Enhanced									"HPA037415: AB_10672346, HPA043207: AB_2678363"			"unprognostic (1.26e-1)"				"unprognostic (1.01e-3)"				"unprognostic (6.04e-2)"	"unprognostic (3.64e-1)"	"prognostic favourable (4.14e-6)"	"unprognostic (1.37e-1)"	"unprognostic (7.36e-2)"			0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	55.3	0.0	0.0	44.6	0.1	0.0	0.1	0.1	30.0	0.1	0.1	0.1	28.7	0.5	0.1	0.0	0.1	0.0	0.1	0.4	0.0	0.1	0.0	0.0	0.5	1.7	0.0	0.1	0.0	0.1	0.1	167.3	0.0	0.1	0.1	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
SULT1B1	ST1B2	ENSG00000173597	"Sulfotransferase family 1B member 1"	O43704	4	69721162-69787961	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"intestine: 137.6"	"Group enriched"	"Detected in some"	5	"HUVEC TERT2: 47.5;TIME: 15.4;U-2197: 13.7"	"Group enriched"	"Detected in some"	11	"colorectal cancer: 7.6;liver cancer: 2.6;pancreatic cancer: 5.5;stomach cancer: 5.5"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"neutrophil: 21.9"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 21.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA002107	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"				"Golgi apparatus"	"Golgi apparatus"	"HPA002107: AB_2666542"	"unprognostic (9.58e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.77e-2)"	"unprognostic (5.14e-2)"	"unprognostic (8.78e-2)"	"unprognostic (2.81e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.15e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.06e-2)"	"unprognostic (6.93e-2)"	"unprognostic (5.46e-2)"	1.2	0.6	0.9	9.3	1.8	1.3	1.1	0.5	1.5	1.1	38.6	0.5	0.7	31.8	0.8	0.6	1.0	1.5	1.2	1.2	0.9	0.9	1.1	24.8	2.4	12.9	1.2	0.7	0.7	0.5	0.0	0.4	0.6	2.0	0.6	20.3	1.3	0.6	0.2	0.4	0.4	137.6	1.4	3.6	13.3	13.9	0.5	0.7	2.0	0.6	0.3	2.0	0.7	1.2	0.2	1.8	21.9	3.2	1.8	3.6	1.6	0.3	0.2	0.3	0.4	0.8	0.9	0.6	0.4	0.2	0.1	0.1	0.3	0.3	0.5	0.3	0.4	0.5	0.0	0.1	0.3	0.6	0.4	0.5	0.4	0.2	1.2	0.6	0.7	5.5	0.0	0.1	0.2	47.5	0.2	1.1	0.4	0.3	0.3	0.5	0.4	0.2	0.2	1.6	0.3	0.1	0.8	0.7	0.4	0.2	0.2	0.2	0.7	0.3	15.4	0.4	0.8	13.7	0.3	0.8	0.4	0.2	0.2	1.4	0.6	5.8	3.2	0.8	0.7	1.9	0.2	0.1	1.1	0.3	1.8	0.2	3.6	1.7	21.9	1.8	2.2	0.2	0.5	1.6	0.9	1.8	0.5	1.5	0.9	0.9	1.2	0.7	2.0	0.7
TMC5	FLJ13593	ENSG00000103534	"Transmembrane channel like 5"	Q6UXY8	16	19410496-19499113	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"intestine: 108.7"	"Cell line enriched"	"Detected in some"	6	"CAPAN-2: 38.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA040810, HPA042037"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA040810: AB_10795627, HPA042037: AB_10804126"	"unprognostic (2.47e-2)"	"unprognostic (3.68e-1)"	"unprognostic (3.50e-2)"	"unprognostic (2.74e-3)"	"unprognostic (1.01e-1)"	"unprognostic (3.64e-2)"	"prognostic unfavourable (7.96e-4)"	"unprognostic (1.21e-1)"	"unprognostic (1.59e-1)"	"unprognostic (9.74e-2)"	"unprognostic (3.27e-2)"	"unprognostic (3.71e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.69e-1)"	"unprognostic (7.88e-2)"	"unprognostic (8.88e-3)"	"unprognostic (1.75e-1)"	0.7	0.3	0.3	4.8	0.3	0.1	5.6	0.3	0.7	3.8	66.1	0.6	0.6	19.1	2.1	16.9	1.4	1.9	15.9	0.4	0.4	0.3	0.3	1.8	17.6	0.2	0.3	0.4	1.8	5.4	4.5	1.0	3.7	1.0	8.4	9.8	1.7	18.9	0.2	0.3	0.8	108.7	0.3	0.2	0.3	19.5	2.6	0.2	0.2	0.8	1.7	4.1	1.5	1.1	0.5	0.7	2.2	0.6	0.9	0.8	0.3	3.6	6.0	0.0	0.1	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	38.9	0.0	0.2	0.0	2.4	0.6	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.1	1.4	1.7	0.0	0.0	1.4	0.1	0.1	0.4	0.1	0.0	1.2	0.0	0.5	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.3	0.6	0.2	0.3	0.3	0.2	0.4	0.8	0.3	0.2	0.5	0.2	0.3	2.2	0.9	0.4	0.7	0.1	0.3	0.3	0.3	0.3	0.7	0.4	0.3	0.3	0.4	1.0	0.2
VIL1	"D2S1471, VIL"	ENSG00000127831	"Villin 1"	P09327	2	218419092-218453295	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"intestine: 129.3"	"Group enriched"	"Detected in some"	106	"CACO-2: 122.1;Hep G2: 57.3"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 56.4"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	6	"neutrophil: 2.5"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 2.5"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"CAB002452, HPA006884, HPA006885"	Enhanced		Enhanced	"Plasma membrane"		41000000	41000000	"Plasma membrane"	"Plasma membrane"	"CAB002452: AB_564052, HPA006884: AB_1080566, HPA006885: AB_1080564"	"unprognostic (1.28e-1)"	"unprognostic (1.91e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.36e-1)"	"unprognostic (3.03e-1)"	"unprognostic (5.90e-2)"	"unprognostic (2.44e-2)"	"unprognostic (7.06e-2)"	"unprognostic (4.14e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.25e-3)"	"unprognostic (3.90e-1)"	"unprognostic (2.58e-1)"	"unprognostic (4.79e-2)"	"unprognostic (4.65e-2)"	0.3	0.2	0.6	5.7	0.8	0.0	0.3	0.7	0.4	0.3	36.6	0.3	0.3	68.9	0.3	1.2	0.3	0.2	22.6	0.3	0.5	0.5	4.6	6.1	0.3	0.3	0.5	0.3	0.3	7.2	0.0	0.4	0.3	0.3	0.3	32.6	0.3	0.5	0.3	0.3	0.3	129.3	1.2	0.5	0.4	0.9	0.6	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.1	0.4	2.5	0.1	0.1	0.1	7.8	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	122.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	57.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	2.5	0.1	0.0	0.4	0.0	7.8	0.6	0.8	0.7	0.4	0.5	0.5	0.5	0.3	0.3	0.3
ZG16	"hZG16, JCLN, JCLN1, ZG16A"	ENSG00000174992	"Zymogen granule protein 16"	O60844	16	29778240-29782973	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"intestine: 84.6"	"Cell line enhanced"	"Detected in some"		"MCF7: 1.8;SK-BR-3: 6.9"	"Cancer enriched"	"Detected in some"	6	"colorectal cancer: 21.7"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"							"HPA052066, HPA052512"	Enhanced				"Secreted to digestive system"	250000	250000			"HPA052066: AB_2681716, HPA052512: AB_2681857"	"unprognostic (1.64e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.60e-3)"	"unprognostic (8.20e-2)"		"unprognostic (3.50e-2)"	"unprognostic (1.93e-2)"	"unprognostic (5.14e-2)"		"unprognostic (1.65e-1)"	"unprognostic (7.77e-2)"	"unprognostic (3.27e-1)"		"unprognostic (2.56e-2)"	"unprognostic (9.99e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.42e-1)"	0.2	0.0	0.2	13.3	0.2	0.0	0.2	0.2	0.2	0.2	67.8	0.2	0.2	9.9	0.2	0.2	0.2	0.1	0.4	0.2	0.2	0.0	0.2	3.6	0.2	0.2	0.2	0.2	0.2	8.9	0.0	0.2	0.2	0.2	0.2	84.6	0.2	0.2	0.2	0.2	0.0	51.6	2.3	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.7	0.2	0.4	0.7	1.1	1.0	0.1	0.7	0.2	0.1	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	1.2	0.1	0.1	0.2	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.8	0.0	1.2	0.1	0.1	0.0	0.1	0.7	0.0	0.3	0.2	0.4	0.0	6.9	0.0	0.4	0.0	0.1	0.0	0.0	0.7	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.4	0.7	0.1	0.5	0.3	0.6	0.3	0.6	0.5	0.0	0.7	0.9	1.0	0.4	1.1	0.3	0.2	0.5	0.1	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2
ACE	"ACE1, CD143, DCP1"	ENSG00000159640	"Angiotensin I converting enzyme"	P12821	17	63477061-63498380	"Candidate cardiovascular disease genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"intestine: 205.6"	"Group enriched"	"Detected in some"	4	"ASC TERT1: 35.9;HUVEC TERT2: 18.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 3.7"	"Group enriched"	"Detected in many"	23	"B-cells: 3.7;monocytes: 2.0;T-cells: 1.9"									"CAB002426, CAB002921, HPA029298, HPA069790"	Enhanced		Approved	Vesicles	"Secreted to blood"	92000000	92000000	Vesicles	Vesicles	"CAB002426: AB_442052, CAB002921: , HPA029298: AB_10960255, HPA069790: "	"unprognostic (4.72e-2)"	"unprognostic (4.16e-1)"	"unprognostic (1.93e-3)"	"unprognostic (6.06e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.35e-2)"	"unprognostic (4.37e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.25e-2)"	"unprognostic (3.13e-2)"	"unprognostic (2.38e-1)"	"unprognostic (7.66e-2)"	"unprognostic (9.07e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.76e-2)"	6.8	2.0	0.5	2.4	4.2	0.0	2.9	0.5	1.1	5.3	83.2	0.7	37.7	46.4	4.5	5.1	1.7	1.5	4.4	4.7	0.6	0.7	2.6	1.4	16.3	2.2	0.4	0.7	1.4	3.0	3.6	3.6	3.6	0.8	3.4	1.4	1.7	2.5	20.1	3.6	1.3	205.6	2.4	0.6	1.4	1.9	32.6	1.3	0.5	6.9	3.1	2.2	1.7	1.6	3.7	0.1	0.0	2.0	0.0	1.9	0.4	0.0	0.0	0.0	0.0	1.5	35.9	0.4	1.3	2.6	0.0	0.0	0.5	3.1	0.7	1.0	6.1	0.0	1.7	0.0	0.0	0.0	0.7	3.4	0.0	0.0	0.8	0.0	0.0	2.4	0.0	0.0	0.0	18.3	3.0	0.0	0.0	0.6	0.0	0.7	0.2	0.3	0.1	0.2	0.5	0.0	0.0	4.5	3.2	0.0	0.0	0.0	1.6	0.2	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.4	0.6	0.9	3.7	1.9	1.4	0.1	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.4	0.5	4.2	0.5	1.1	0.6	0.7	0.4	0.7	0.8	1.3
ACE2		ENSG00000130234	"Angiotensin I converting enzyme 2"	Q9BYF1	X	15561033-15602148	"Enzymes, FDA approved drug targets, Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"intestine: 122.0"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.4;HaCaT: 4.1;Hep G2: 2.4;NB-4: 2.2;RPMI-8226: 2.0;RT4: 2.4;SH-SY5Y: 2.8"	"Cancer enhanced"	"Detected in many"		"renal cancer: 26.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA000288, CAB026174"	Enhanced				"Secreted to blood"	85000	85000			"CAB026174: , HPA000288: AB_1078160"	"unprognostic (1.40e-1)"	"unprognostic (7.26e-2)"	"unprognostic (2.76e-2)"	"unprognostic (5.71e-2)"	"unprognostic (2.51e-1)"	"unprognostic (5.26e-2)"	"prognostic favourable (4.21e-4)"	"unprognostic (2.34e-2)"	"unprognostic (6.74e-3)"	"unprognostic (2.54e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.74e-1)"	"prognostic favourable (2.12e-5)"	"unprognostic (1.94e-1)"	"unprognostic (9.62e-2)"	"unprognostic (2.11e-1)"	"unprognostic (7.10e-2)"	4.5	0.4	0.2	0.8	0.2	0.0	2.3	0.2	0.2	0.4	49.1	0.2	2.3	46.0	0.4	2.7	1.2	0.6	16.4	10.5	0.2	0.1	23.2	1.2	0.8	0.6	0.2	0.2	1.3	1.6	0.0	0.2	1.0	0.2	0.5	1.3	0.2	1.1	1.2	0.7	0.2	122.0	0.3	0.2	0.2	0.5	17.9	0.2	0.2	4.5	0.5	0.2	0.4	0.9	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.2	0.0	0.4	0.0	0.7	0.0	2.4	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.6	0.0	4.1	0.2	0.1	0.0	0.1	0.1	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	2.2	0.1	0.2	0.0	0.0	2.0	0.4	2.4	0.6	2.8	0.1	0.3	0.2	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2
ACSL5	"ACS2, ACS5, FACL5"	ENSG00000197142	"Acyl-CoA synthetase long chain family member 5"	Q9ULC5	10	112374018-112428380	"Enzymes, Plasma proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"intestine: 278.7"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 42.4;RT4: 43.4;U-937: 21.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007162, CAB035986, CAB062546"	Enhanced		Supported	Nucleoplasm,Mitochondria		22000	22000	Mitochondria	Mitochondria	"CAB035986: AB_941506, CAB062546: AB_2665614, HPA007162: AB_2667761"	"unprognostic (5.75e-3)"	"unprognostic (2.06e-1)"	"unprognostic (3.08e-2)"	"prognostic favourable (1.13e-4)"	"unprognostic (2.45e-1)"	"unprognostic (2.13e-2)"	"unprognostic (4.92e-2)"	"unprognostic (5.90e-2)"	"unprognostic (1.67e-1)"	"unprognostic (4.06e-2)"	"unprognostic (4.18e-3)"	"unprognostic (7.40e-2)"	"unprognostic (5.25e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.10e-1)"	"unprognostic (5.92e-3)"	"unprognostic (1.08e-3)"	10.0	1.4	3.1	12.7	3.5	2.2	6.4	1.2	3.1	9.3	84.6	1.6	3.8	64.5	8.7	41.8	4.2	8.0	11.2	3.1	3.3	3.1	3.2	56.5	10.8	7.1	4.0	1.2	5.0	1.6	0.1	1.2	2.1	3.9	7.0	21.5	8.4	2.4	4.0	2.6	1.3	278.7	2.6	3.8	12.4	7.7	2.3	2.5	6.3	3.1	2.7	7.2	17.4	6.7	10.8	19.4	16.3	17.0	16.2	25.1	11.7	11.4	0.2	0.2	0.0	0.8	0.1	1.0	0.3	2.2	0.0	0.1	10.4	42.4	14.0	2.6	0.5	0.1	0.0	0.0	0.2	11.6	0.0	10.9	0.4	18.1	2.8	16.9	18.5	1.9	0.0	0.2	0.0	0.8	0.0	6.3	0.0	0.0	0.0	7.8	0.0	0.4	3.8	0.0	8.5	1.1	43.4	0.0	0.2	16.9	6.5	0.0	0.0	9.5	12.3	0.1	0.1	0.7	0.7	4.6	0.0	6.8	0.3	21.2	0.0	14.5	9.3	16.3	16.7	17.0	16.6	10.8	13.7	18.4	19.4	8.2	9.5	14.5	2.5	16.2	15.9	6.2	25.1	11.7	3.1	3.5	1.2	3.1	3.3	3.1	4.0	1.2	3.9	2.5
AMN	amnionless	ENSG00000166126	"Amnion associated transmembrane protein"	Q9BXJ7	14	102922656-102933596	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"intestine: 97.6"	"Cell line enhanced"	"Detected in some"		"CACO-2: 11.0;Hep G2: 10.8;U-698: 5.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.8"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA000817	Approved									"HPA000817: AB_1078146"	"unprognostic (2.02e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.94e-3)"	"unprognostic (7.39e-3)"	"unprognostic (9.32e-2)"	"unprognostic (1.88e-3)"	"unprognostic (8.68e-2)"	"unprognostic (1.62e-1)"	"unprognostic (4.37e-2)"	"unprognostic (2.97e-2)"	"unprognostic (7.57e-2)"	"unprognostic (2.43e-2)"	"prognostic favourable (9.62e-5)"	"unprognostic (8.02e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.66e-1)"	0.4	0.0	0.1	3.3	0.1	0.0	0.7	0.1	0.1	0.6	44.3	0.1	0.2	19.3	0.2	3.1	2.6	0.6	10.4	0.2	0.1	0.0	17.2	17.8	1.8	0.5	0.1	0.0	0.1	0.2	0.0	0.4	0.2	0.1	0.4	2.1	0.2	0.7	0.0	0.0	0.9	97.6	0.1	0.0	0.6	3.9	0.3	0.1	0.7	0.7	0.1	1.1	0.5	1.0	0.3	1.8	0.0	0.0	0.0	0.7	0.1	0.6	0.1	0.0	0.1	0.0	0.0	2.5	0.0	0.0	0.0	0.0	11.0	0.3	0.0	0.2	0.0	1.8	0.0	0.0	0.0	0.5	0.2	0.0	0.8	10.8	0.1	0.0	0.7	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.9	1.6	0.2	0.0	0.2	0.1	0.2	0.0	0.0	1.0	0.7	0.1	0.1	0.1	0.0	1.4	0.0	0.0	0.0	0.2	0.0	1.0	0.6	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.3	0.0	0.0	0.0	0.3	0.7	0.6	0.0	0.0	0.0	1.8	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1
ATOH1	"bHLHa14, HATH1, MATH-1, Math1"	ENSG00000172238	"Atonal bHLH transcription factor 1"	Q92858	4	93828753-93830964	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	5	"intestine: 29.5"	"Cell line enhanced"	"Detected in some"		"HAP1: 3.6;HL-60: 2.3"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 9.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"																"prognostic favourable (3.26e-5)"								"unprognostic (5.20e-1)"	"unprognostic (2.69e-1)"		"unprognostic (1.26e-1)"	"unprognostic (2.70e-1)"			0.0	0.0	0.1	6.4	0.1	0.0	0.1	0.1	0.1	0.1	22.5	0.0	0.0	8.8	0.1	0.0	0.1	0.1	2.7	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	15.0	0.0	0.1	0.0	0.0	0.1	29.5	0.2	0.1	0.1	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.6	0.3	0.0	0.0	2.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.8	0.5	0.0	0.2	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
BEST4	VMD2L2	ENSG00000142959	"Bestrophin 4"	Q8NFU0	1	44783585-44787705	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"intestine: 34.3"	"Cell line enhanced"	"Detected in some"		"Hep G2: 7.3;U-698: 5.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA058564	Uncertain									"HPA058564: AB_2683759"	"unprognostic (5.76e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.15e-2)"	"unprognostic (6.20e-2)"	"unprognostic (6.51e-3)"	"unprognostic (1.09e-1)"	"unprognostic (8.39e-2)"	"unprognostic (1.45e-3)"	"unprognostic (1.04e-1)"	"unprognostic (8.97e-2)"	"unprognostic (5.72e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.69e-5)"	"unprognostic (1.43e-1)"	"unprognostic (3.72e-1)"	"unprognostic (1.28e-1)"	"unprognostic (4.13e-3)"	0.5	1.1	0.6	1.4	2.5	0.4	0.5	2.1	0.7	1.2	32.7	0.5	0.5	8.8	0.7	2.6	0.5	7.2	0.5	0.5	1.0	3.2	0.5	0.5	1.1	0.5	0.5	0.5	0.5	0.5	0.4	1.8	0.5	0.5	0.5	15.9	0.5	0.5	0.5	0.5	1.8	34.3	0.5	0.5	0.5	0.2	0.5	0.5	0.5	0.5	0.5	0.5	0.5	0.5	3.0	0.9	0.7	0.1	0.9	2.8	0.4	0.2	0.6	1.1	1.2	0.4	0.4	3.4	0.8	0.4	0.3	0.1	0.4	1.5	0.3	1.5	0.4	1.6	0.2	0.2	0.4	0.7	0.7	0.2	1.8	7.3	0.4	0.0	0.9	0.7	0.9	0.4	0.7	1.0	0.2	0.6	0.2	0.2	0.0	0.5	2.4	0.2	0.4	0.3	0.6	0.5	0.1	2.5	0.9	0.3	0.2	0.3	1.2	0.1	1.7	0.5	0.5	0.5	0.5	1.2	0.3	5.2	1.2	0.3	0.2	0.1	0.1	0.5	1.1	0.1	2.7	3.0	1.9	2.8	0.0	2.0	1.0	1.8	0.7	0.9	0.0	0.9	2.2	0.4	0.6	2.5	2.1	0.7	1.0	3.2	0.5	0.5	0.5	0.5
BTNL3	"BTN9.1, BTNLR"	ENSG00000168903	"Butyrophilin like 3"	Q6UXE8	5	180988845-181006727	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"intestine: 82.5"	"Cell line enhanced"	"Detected in some"		"BEWO: 1.0;CACO-2: 2.4;HMC-1: 1.0;RPMI-8226: 2.4;U-266/84: 2.4"	"Group enriched"	"Detected in some"	7	"colorectal cancer: 5.5;pancreatic cancer: 1.2;stomach cancer: 2.3"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	178	"neutrophil: 17.8"	"Lineage enriched"	"Detected in single"	178	"granulocytes: 17.8"																						"unprognostic (4.07e-2)"		"unprognostic (3.64e-2)"	"unprognostic (9.21e-2)"	"unprognostic (4.00e-1)"	"unprognostic (2.00e-1)"		"unprognostic (1.10e-1)"	"unprognostic (5.57e-2)"		"unprognostic (2.19e-2)"	"unprognostic (5.41e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.33e-1)"		0.1	0.0	0.1	2.1	0.1	0.0	0.1	0.1	0.1	0.1	32.5	0.1	0.1	44.2	0.1	0.1	0.1	0.1	0.4	0.1	0.1	0.0	0.1	0.1	0.4	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	9.4	0.1	0.1	0.1	0.1	0.0	82.5	0.1	0.1	0.5	0.4	0.7	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.0	17.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	2.4	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.8	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
C3orf85	FLJ22763	ENSG00000241224	"Chromosome 3 open reading frame 85"		3	109118252-109150514	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"			"Tissue enriched"	"Detected in some"	5	"intestine: 50.1"	"Cell line enhanced"	"Detected in some"		"BEWO: 1.2;CACO-2: 4.9;RPMI-8226: 1.4;SH-SY5Y: 1.5"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 1.3"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																"unprognostic (9.10e-2)"				"unprognostic (9.48e-3)"						"unprognostic (3.80e-4)"	"unprognostic (1.15e-1)"	"unprognostic (6.70e-2)"			0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	14.6	0.0	0.0	36.2	0.0	0.6	0.0	0.0	0.0	0.4	0.0		6.8	9.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	50.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	4.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.2	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CA7		ENSG00000168748	"Carbonic anhydrase 7"	P43166	16	66844379-66854153	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	5	"intestine: 37.2"	"Cell line enhanced"	"Detected in some"		"CACO-2: 1.2;HAP1: 1.8;NTERA-2: 1.5;REH: 3.3;SCLC-21H: 2.7;THP-1: 5.5"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 0.9"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA047237	Uncertain									"HPA047237: AB_2679994"	"unprognostic (8.77e-4)"	"unprognostic (5.23e-4)"	"unprognostic (1.57e-1)"	"unprognostic (1.96e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.16e-2)"		"unprognostic (7.90e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.84e-2)"	"unprognostic (9.62e-2)"	"unprognostic (1.69e-2)"	"unprognostic (7.12e-3)"	"unprognostic (8.47e-2)"	"unprognostic (5.20e-1)"	"unprognostic (1.90e-2)"	"unprognostic (6.46e-2)"	0.2	0.2	3.2	0.4	7.5	0.2	0.2	3.9	7.7	0.2	37.2	0.3	0.0	4.8	0.3	0.9	0.3	0.2	0.2	0.2	6.3	0.5	0.2	0.2	0.2	0.2	0.7	2.9	0.2	0.2	0.2	0.0	0.2	1.8	0.2	32.0	0.0	1.1	0.4	0.2	0.2	22.8	1.0	0.1	0.2	0.2	0.5	1.3	0.1	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.2	0.0	0.4	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.9	3.3	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	7.5	3.9	7.7	6.3	0.5	0.7	2.9	1.8	1.3
ENPP7	"alk-SMase, NPP7"	ENSG00000182156	"Ectonucleotide pyrophosphatase/phosphodiesterase 7"	Q6UWV6	17	79730919-79742222	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"intestine: 71.1"	"Group enriched"	"Detected in some"	5	"Hep G2: 2.8;Karpas-707: 5.1;U-266/70: 6.9"	"Cancer enriched"	"Detected in some"	6	"liver cancer: 6.4"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"memory B-cell: 1.3"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA024603	Approved				"Intracellular and membrane"	440000	440000			"HPA024603: AB_1848174"	"unprognostic (4.00e-2)"	"unprognostic (1.16e-2)"	"unprognostic (6.49e-2)"	"unprognostic (4.83e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.01e-1)"		"unprognostic (8.45e-4)"	"unprognostic (4.83e-2)"		"unprognostic (1.18e-2)"	"unprognostic (1.52e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.80e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.6	0.0	0.0	21.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	14.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	71.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.4	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.5	0.0	0.0	0.5	0.0	0.9	0.0	0.1	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.9	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.7	1.3	0.1	0.4	0.0	0.9	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ENTPD8	"NTPDase-8, UNQ2492"	ENSG00000188833	"Ectonucleoside triphosphate diphosphohydrolase 8"	Q5MY95	9	137434364-137441816	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"intestine: 48.1"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 9.0;RPMI-8226: 8.7;T-47d: 4.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA021509	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA021509: AB_1848185"	"unprognostic (3.85e-2)"	"unprognostic (8.33e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.40e-1)"	"unprognostic (6.46e-3)"	"unprognostic (8.70e-2)"	"unprognostic (3.87e-2)"	"unprognostic (8.48e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.08e-5)"	"prognostic favourable (7.17e-4)"	"unprognostic (2.17e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.78e-1)"	0.4	0.0	0.4	2.6	0.4	0.0	0.4	0.4	0.4	0.4	19.2	0.4	0.4	18.5	0.4	0.4	0.4	0.3	2.2	0.4	0.5	0.0	2.1	9.8	0.8	0.4	0.4	0.4	0.4	1.8	0.0	4.2	0.5	0.4	0.4	7.5	0.8	4.1	0.4	0.4	0.0	48.1	0.4	0.4	0.4	6.1	0.4	0.4	0.6	0.4	0.4	0.4	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.1	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.2	2.0	9.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	1.5	0.2	0.0	0.6	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	1.6	0.0	0.2	0.1	0.4	0.0	0.0	8.7	1.4	0.0	0.3	0.9	0.2	0.0	0.1	4.7	0.2	0.1	0.0	2.4	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.4	0.4	0.5	0.0	0.4	0.4	0.4	0.4
GPR35		ENSG00000178623	"G protein-coupled receptor 35"	Q9HC97	2	240605431-240631259	"G-protein coupled receptors, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"intestine: 109.6"	"Cell line enhanced"	"Detected in some"		"CACO-2: 11.1;CAPAN-2: 27.9;HDLM-2: 9.3;Hep G2: 17.7;HMC-1: 17.6;NB-4: 8.6;U-937: 9.7"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 20.7"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	12	"classical monocyte: 16.4;eosinophil: 16.8;intermediate monocyte: 22.7;myeloid DC: 14.5;non-classical monocyte: 6.1"	"Group enriched"	"Detected in many"	14	"dendritic cells: 14.5;granulocytes: 16.8;monocytes: 22.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"														"unprognostic (1.05e-1)"	"unprognostic (2.89e-2)"	"unprognostic (4.35e-2)"	"unprognostic (1.53e-1)"	"unprognostic (5.99e-2)"	"unprognostic (3.94e-3)"	"unprognostic (2.71e-2)"	"prognostic unfavourable (5.86e-4)"	"unprognostic (2.01e-1)"	"unprognostic (2.07e-1)"	"unprognostic (7.98e-2)"	"unprognostic (1.36e-2)"	"prognostic unfavourable (2.59e-5)"	"unprognostic (7.03e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.10e-3)"	0.8	0.2	1.5	7.0	1.8	2.4	1.4	2.4	2.2	1.6	50.4	1.0	0.5	27.2	1.7	1.8	1.1	3.4	24.1	0.8	1.5	1.5	2.2	0.7	3.1	6.6	1.6	0.8	2.5	0.5	0.3	3.2	0.7	1.8	1.8	11.2	0.6	0.8	0.7	3.9	1.2	109.6	1.3	1.4	8.9	10.8	2.0	1.6	1.9	1.2	0.9	2.4	1.0	1.0	0.0	14.5	16.8	22.7	0.3	1.3	5.5	0.0	0.2	0.1	0.6	0.5	0.0	0.2	0.0	0.2	0.0	0.1	11.1	27.9	0.1	0.1	0.1	0.2	0.0	0.0	0.0	9.3	0.3	4.6	0.2	17.7	0.2	0.2	17.6	0.1	0.1	0.3	0.1	0.0	0.2	1.6	0.0	0.3	0.2	8.6	0.4	0.1	1.0	0.0	0.2	0.1	0.1	1.1	0.4	0.0	0.1	0.2	0.1	3.1	0.4	0.1	0.1	0.7	0.1	1.9	0.8	0.1	0.0	9.7	0.2	0.0	16.4	16.8	0.7	22.7	1.3	0.0	0.4	0.4	14.5	0.0	0.2	0.5	0.2	0.3	6.1	0.3	0.1	5.5	1.5	1.8	2.4	2.2	1.5	1.5	1.6	0.8	1.8	1.6
HIST1H4G	"H4/l, H4FL"	ENSG00000275663	"Histone cluster 1 H4 family member g"	Q99525	6	26246681-26246977	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	5	"intestine: 2.1"	"Group enriched"	"Detected in some"	20	"AF22: 1.0;CAPAN-2: 1.2;PC-3: 3.3;SCLC-21H: 1.7;THP-1: 2.4"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA042201	Supported									"HPA042201: AB_2677898"																		0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.3			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.7		0.0	0.0	0.0	0.0	2.1	0.0		0.0	0.0	0.0			0.0		0.0	0.0		0.0	0.0	0.3	0.0	0.4	0.3	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0										
HKDC1	"FLJ22761, FLJ37767"	ENSG00000156510	"Hexokinase domain containing 1"	Q2TB90	10	69220303-69267559	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"intestine: 77.4"	"Cell line enhanced"	"Detected in some"		"A549: 14.7;CACO-2: 20.9;CAPAN-2: 41.4;EFO-21: 12.8;Hep G2: 12.1;RPTEC TERT1: 30.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 8.3;T-reg: 6.6"	"Lineage enriched"	"Detected in single"	29	"T-cells: 8.3"	"Region enhanced"	"Detected in some"		"cerebral cortex: 12.2"	"Low region specificity"	"Detected in all"			"HPA011956, HPA064198, HPA064230"	Approved		Enhanced	Mitochondria				Mitochondria	Mitochondria	"HPA011956: AB_1850758, HPA064198: AB_2685210, HPA064230: "	"unprognostic (1.29e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.86e-1)"	"unprognostic (8.47e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.05e-1)"	"unprognostic (6.31e-3)"	"unprognostic (5.03e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.23e-3)"	"unprognostic (3.11e-1)"	"unprognostic (1.04e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.24e-1)"	"unprognostic (2.10e-3)"	"unprognostic (2.19e-1)"	0.2	0.0	0.9	1.2	1.6	0.0	0.2	0.8	1.4	0.5	29.8	0.5	0.2	29.9	0.5	1.0	0.3	2.5	11.2	0.2	0.5	0.6	15.6	4.6	1.3	0.3	0.3	0.2	1.0	4.7	0.0	0.5	0.2	0.4	0.2	2.3	12.0	0.2	0.2	0.2	0.0	77.4	0.2	0.2	0.2	0.4	0.6	0.2	0.2	5.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.2	8.3	1.6	0.4	14.7	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	20.9	41.4	0.0	12.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	12.1	1.0	0.0	0.0	0.0	0.1	0.1	1.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.4	0.0	30.9	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.6	0.1	0.2	0.0	0.0	0.0	3.1	0.0	0.2	0.0	0.0	0.0	0.9	0.0	0.7	0.0	4.4	1.4	0.0	0.0	8.3	3.2	0.0	0.2	0.0	0.0	6.6	1.6	0.9	1.6	0.8	0.4	0.5	0.6	0.3	0.2	0.4	0.2
LRRC75A	"C17orf76, FAM211A, FLJ35696"	ENSG00000181350	"Leucine rich repeat containing 75A"	Q8NAA5	17	16441577-16492153	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"intestine: 42.3"	"Cell line enhanced"	"Detected in some"		"HEL: 11.8;HUVEC TERT2: 3.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA028528, HPA065840"	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol				Nucleoplasm	Nucleoplasm	"HPA028528: AB_10600755, HPA065840: "	"unprognostic (1.09e-1)"	"unprognostic (5.60e-2)"	"unprognostic (5.79e-2)"	"unprognostic (3.85e-5)"	"unprognostic (3.93e-2)"	"unprognostic (3.23e-2)"	"unprognostic (3.44e-1)"	"unprognostic (7.66e-3)"	"unprognostic (7.74e-2)"	"unprognostic (2.84e-1)"	"prognostic favourable (7.46e-5)"	"unprognostic (8.36e-2)"	"unprognostic (4.28e-3)"	"unprognostic (8.84e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.17e-3)"	"unprognostic (2.06e-1)"	1.0	8.9	5.2	2.8	3.7	1.7	0.6	0.7	6.3	2.2	26.3	1.5	1.4	15.0	1.9	0.5	0.4	0.9	0.5	0.4	4.1	2.4	0.8	0.2	1.6	1.9	1.6	3.2	1.8	1.6	3.7	4.1	1.5	2.1	1.1	10.4	1.9	0.3	1.7	0.4	0.4	42.3	3.0	0.8	6.4	1.3	8.5	0.4	0.5	1.2	0.0	1.9	1.3	0.7	0.8	0.0	0.3	0.6	0.3	0.6	0.2	1.1	1.0	1.2	0.8	0.3	0.5	0.1	0.3	0.8	2.7	2.2	1.1	0.3	0.0	0.8	0.1	0.4	0.3	0.2	0.1	0.4	0.9	11.8	0.6	0.0	0.4	0.2	0.9	0.0	0.0	0.6	0.0	3.8	0.5	0.2	0.0	1.9	1.9	0.8	0.2	0.1	0.6	0.7	0.1	0.5	0.2	2.3	0.6	0.0	0.2	2.8	0.2	0.1	0.0	0.3	1.4	0.9	1.5	1.5	0.3	0.2	0.1	0.7	1.0	0.0	0.3	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.6	0.3	0.3	0.6	0.0	0.0	0.2	5.2	3.7	0.7	6.3	4.1	2.4	1.6	3.2	2.1	0.4
NHSL1	"bA43P8.1, C6orf63, KIAA1357"	ENSG00000135540	"NHS like 1"	Q5SYE7	6	138422043-138692571	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"intestine: 93.0"	"Cell line enhanced"	"Detected in many"		"Hep G2: 22.1;TIME: 31.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 3.8;non-classical monocyte: 3.8"	"Group enriched"	"Detected in many"	14	"dendritic cells: 1.2;granulocytes: 1.0;monocytes: 3.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029966, HPA029967"	Uncertain		Approved	"Nucleoplasm,Nuclear membrane"				"Nuclear membrane"	"Nuclear membrane"	"HPA029966: AB_10601972, HPA029967: AB_2673271"	"unprognostic (1.85e-1)"	"unprognostic (9.71e-2)"	"unprognostic (6.19e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.93e-1)"	"unprognostic (3.27e-1)"	"unprognostic (8.34e-2)"	"unprognostic (5.21e-2)"	"unprognostic (9.99e-2)"	"unprognostic (1.10e-1)"	"unprognostic (8.00e-2)"	"unprognostic (4.19e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.52e-1)"	"unprognostic (6.55e-2)"	"unprognostic (4.06e-2)"	7.4	1.1	6.0	5.4	5.7	0.2	2.4	3.7	8.6	2.2	46.3	4.3	3.4	13.4	3.0	11.2	10.0	0.9	7.2	18.4	4.8	3.4	17.4	19.5	15.0	2.0	4.2	1.3	1.2	4.6	2.8	1.7	3.5	6.3	1.7	10.0	7.9	3.4	0.4	2.3	10.5	93.0	3.0	2.8	2.0	6.8	1.6	1.6	0.2	1.2	3.6	1.7	2.4	3.9	0.1	1.2	1.0	3.8	0.1	0.1	0.7	2.6	2.3	16.4	6.9	4.8	5.9	6.1	2.3	1.1	0.8	0.8	3.0	1.5	0.0	3.0	2.0	6.0	9.9	6.1	0.4	0.2	6.6	1.6	1.1	22.1	7.1	5.8	1.1	8.5	3.5	0.4	7.1	11.5	0.0	0.9	3.6	5.1	0.6	0.4	6.5	4.3	6.7	1.7	0.5	5.6	6.7	6.2	0.0	2.5	5.1	16.5	1.6	1.8	31.5	2.3	2.3	2.3	6.5	0.6	1.2	0.0	0.2	2.4	12.6	1.0	3.4	0.5	0.1	3.8	0.1	0.1	0.0	0.1	1.2	0.0	0.1	0.1	0.1	0.1	3.8	0.7	0.0	0.7	6.0	5.7	3.7	3.5	4.8	3.4	4.2	1.3	6.3	1.6
NTS		ENSG00000133636	Neurotensin	P30990	12	85874295-85882992	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"intestine: 115.3"	"Cell line enriched"	"Detected in some"	5	"HEL: 32.5"	"Cancer enhanced"	"Detected in many"		"lung cancer: 155.1"	"Group enriched"	"Detected in many"	4	"hippocampal formation: 10.3;hypothalamus: 22.1;midbrain: 6.3;pons and medulla: 25.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"basal ganglia: 81.8"	HPA026664	Enhanced				"Secreted to digestive system"	120000	120000			"HPA026664: AB_2671936"	"unprognostic (3.63e-1)"	"prognostic favourable (9.94e-5)"	"unprognostic (8.18e-2)"	"prognostic unfavourable (5.10e-4)"	"unprognostic (1.99e-2)"	"unprognostic (3.04e-1)"	"unprognostic (7.62e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.53e-3)"	"unprognostic (8.83e-2)"	"unprognostic (1.74e-2)"	"unprognostic (3.76e-2)"	"unprognostic (1.30e-6)"	"unprognostic (2.94e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.17e-1)"	"unprognostic (7.48e-2)"	2.9	0.6	3.9	1.4	3.2	0.1	2.5	0.3	0.4	0.5	5.2	2.5	0.0	2.8	0.2	1.6	2.5	0.5	0.8	0.8	10.3	22.1	0.9	0.7	2.0	15.1	6.3	0.1	0.7	0.4	0.1	15.0	0.3	25.0	0.4	0.7	0.0	1.6	0.5	0.1	0.1	115.3	0.5	2.7	0.2	18.8	0.3	0.4	0.1	0.9	0.8	1.2	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.2	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.0	0.7	32.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	7.2	2.7	0.0	1.1	0.0	0.0	0.0	3.6	1.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	1.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	3.2	0.3	0.4	10.3	22.1	6.3	0.1	25.0	0.4
PLCB3		ENSG00000149782	"Phospholipase C beta 3"	Q01970	11	64251523-64269150	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"intestine: 77.5"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 4.4"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009257, HPA039279, HPA043907"	Enhanced		Enhanced	Nucleoplasm		94000	94000	Nucleoplasm	Nucleoplasm	"CAB009257: AB_654079, HPA039279: AB_2676425, HPA043907: AB_2678726"	"unprognostic (1.30e-1)"	"unprognostic (1.21e-2)"	"unprognostic (2.86e-1)"	"unprognostic (2.35e-1)"	"unprognostic (9.35e-2)"	"unprognostic (6.23e-3)"	"prognostic unfavourable (1.39e-4)"	"unprognostic (2.44e-2)"	"unprognostic (6.61e-2)"	"unprognostic (1.26e-1)"	"unprognostic (8.07e-3)"	"unprognostic (1.00e-2)"	"prognostic unfavourable (4.31e-5)"	"unprognostic (5.04e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.20e-1)"	"unprognostic (3.88e-2)"	5.8	9.7	6.1	7.0	5.4	3.7	10.9	6.3	5.8	8.6	40.6	3.1	8.8	59.3	9.1	5.9	16.8	7.7	11.8	4.8	5.4	2.6	5.5	3.2	9.1	4.8	3.5	2.2	11.0	4.0	7.6	2.9	11.1	4.8	6.4	7.0	5.0	6.5	6.3	3.8	10.7	77.5	7.0	4.5	7.2	8.0	4.6	5.4	4.2	5.0	8.2	9.3	6.3	8.8	0.3	4.4	0.9	1.4	0.3	0.8	0.4	17.6	9.9	9.8	14.6	10.3	8.0	9.8	14.1	10.7	12.1	7.4	8.7	13.5	1.2	8.5	17.7	30.5	11.0	13.2	4.2	8.5	6.1	13.8	20.5	6.5	7.1	3.3	9.1	6.7	8.8	13.1	9.8	17.6	6.8	1.5	15.3	21.3	4.2	7.0	15.9	10.9	9.2	22.1	5.2	7.4	18.7	2.6	10.8	20.9	26.3	10.0	13.8	6.4	30.5	11.2	13.4	25.6	9.1	1.9	0.9	1.4	18.5	7.9	10.3	0.0	1.4	0.2	0.7	1.4	0.8	0.1	0.8	0.7	1.3	0.3	0.4	0.4	0.9	0.3	1.4	4.4	0.2	0.4	6.1	5.4	6.3	5.8	5.4	2.6	3.5	2.2	4.8	5.4
PPP1R14D	"CPI17-like, FLJ20251, GBPI-1, MGC119014, MGC119016"	ENSG00000166143	"Protein phosphatase 1 regulatory inhibitor subunit 14D"	Q9NXH3	15	40815445-40828709	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"intestine: 71.3"	"Cell line enhanced"	"Detected in some"		"Hep G2: 3.5;RPMI-8226: 6.6;RT4: 4.2;SK-BR-3: 2.8;T-47d: 2.6;U-266/84: 4.4"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 45.0"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"							HPA041846	Uncertain									"HPA041846: AB_10794307"	"unprognostic (1.29e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.82e-1)"	"unprognostic (5.91e-3)"	"unprognostic (1.17e-2)"	"unprognostic (4.68e-2)"	"unprognostic (1.89e-1)"	"unprognostic (7.74e-2)"	"unprognostic (2.86e-1)"	"unprognostic (5.26e-3)"	"unprognostic (3.16e-2)"	"prognostic unfavourable (3.07e-4)"	"unprognostic (3.55e-1)"	"unprognostic (1.43e-2)"	"unprognostic (3.74e-3)"	"unprognostic (3.11e-2)"	0.2	0.1	0.2	13.6	0.2	0.0	0.3	0.3	0.2	0.2	33.6	0.2	0.2	33.9	0.2	0.3	0.3	0.4	10.0	0.2	0.2	0.2	2.3	0.2	0.2	0.2	0.2	0.2	0.2	0.3	0.0	0.2	0.2	0.2	0.5	28.9	0.2	0.5	0.2	0.2	0.3	71.3	0.8	0.2	0.2	0.4	0.2	0.2	0.2	0.6	0.2	0.2	0.2	0.2	1.2	1.1	0.4	1.9	0.3	1.0	0.2	0.1	0.8	0.1	0.3	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.6	2.1	0.2	0.3	0.0	0.3	0.0	0.2	0.0	0.3	0.2	0.2	0.5	3.5	0.0	0.5	0.2	0.0	0.4	0.0	0.0	0.0	0.2	1.2	0.0	0.5	0.1	0.4	0.1	0.0	0.0	0.4	6.6	0.0	4.2	1.2	0.8	0.0	2.8	0.0	2.6	0.0	0.0	0.2	0.0	0.1	0.0	0.2	4.4	0.8	0.1	0.1	0.0	0.4	1.2	0.1	0.6	0.9	0.3	0.1	1.0	0.3	0.1	1.2	0.6	0.8	0.4	0.3	1.9	1.1	0.4	0.2	0.2	0.2	0.3	0.2	0.2	0.2	0.2	0.2	0.2	0.2
TM6SF2	Lpr4	ENSG00000213996	"Transmembrane 6 superfamily member 2"	Q9BZW4	19	19264364-19273391	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	5	"intestine: 89.4"	"Cell line enhanced"	"Detected in some"		"Hep G2: 3.3;HHSteC: 4.9;LHCN-M2: 3.8;NTERA-2: 2.6;SH-SY5Y: 4.3"	"Cancer enhanced"	"Detected in many"		"liver cancer: 6.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA066026	Uncertain									"HPA066026: AB_2685598"	"unprognostic (2.41e-1)"	"unprognostic (4.81e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.15e-3)"	"unprognostic (3.29e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.39e-3)"	"unprognostic (4.00e-2)"	"unprognostic (4.15e-2)"	"unprognostic (4.53e-4)"	"unprognostic (9.55e-3)"	"unprognostic (4.37e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.61e-1)"	"unprognostic (4.56e-2)"	"unprognostic (1.51e-1)"	"unprognostic (6.15e-2)"	0.1	0.1	0.2	0.2	0.1	0.0	0.3	0.3	0.3	0.6	43.2	0.2	0.2	36.8	0.4	1.7	0.2	0.2	1.0	0.4	0.2	0.5	3.2	18.5	0.3	0.0	0.1	0.1	0.0	0.1	0.0	0.4	0.1	0.5	0.5	0.9	0.4	0.2	0.4	0.0	0.1	89.4	0.2	0.1	0.1	1.1	0.1	0.1	0.0	0.1	0.0	0.0	0.3	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.9	0.0	0.0	0.4	0.1	2.1	1.2	1.0	1.3	1.0	0.1	0.0	1.0	1.7	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.1	3.3	4.9	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.8	2.6	0.0	0.0	0.0	0.4	0.0	0.0	1.9	4.3	0.0	0.0	0.0	0.0	0.3	0.0	0.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.3	0.3	0.2	0.5	0.1	0.1	0.5	0.1
AQP11		ENSG00000178301	"Aquaporin 11"	Q8NBQ7	11	77589391-77610355	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"intestine: 60.1"	"Cell line enhanced"	"Detected in many"		"CACO-2: 8.7;Hep G2: 14.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"B-cells: 2.0;NK-cells: 2.0;T-cells: 2.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042879			Approved	Nucleoplasm,Vesicles				Nucleoplasm	Nucleoplasm	"HPA042879: AB_10794919"	"unprognostic (4.95e-2)"	"unprognostic (7.61e-2)"	"unprognostic (2.15e-2)"	"unprognostic (9.62e-5)"	"unprognostic (2.42e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.48e-2)"	"unprognostic (2.65e-1)"	"prognostic favourable (9.89e-4)"	"unprognostic (1.16e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.44e-1)"	"unprognostic (6.46e-2)"	"unprognostic (1.66e-3)"	1.0	14.5	4.2	0.8	3.5	0.6	1.1	5.0	4.8	0.6	22.4	2.1	0.7	24.7	0.8	1.2	0.5	0.9	2.4	0.7	2.5	4.5	5.2	13.9	0.6	0.9	3.4	3.4	9.3	3.6	0.9	1.8	3.5	3.4	3.9	2.1	3.8	0.8	0.7	1.0	1.0	60.1	0.6	1.5	1.0	2.3	7.4	1.7	0.0	1.6	0.2	0.4	0.8	0.6	2.0	0.1	0.3	0.1	2.0	2.3	0.8	1.1	3.6	1.5	2.4	3.5	0.9	1.6	1.9	0.8	1.8	0.8	8.7	1.7	1.8	0.9	0.8	1.1	0.6	0.1	0.9	5.3	1.5	1.4	1.2	14.4	1.1	3.0	1.7	0.9	0.3	1.0	0.2	0.3	0.9	1.1	2.0	1.8	1.1	2.0	1.6	3.4	1.6	3.9	0.6	1.0	1.4	1.5	1.1	2.4	0.5	0.9	1.8	0.4	1.0	1.4	4.6	2.8	1.2	1.2	0.8	1.4	0.5	0.2	2.0	0.0	0.0	0.3	1.9	0.0	1.3	0.3	0.8	1.5	0.1	2.0	2.3	0.7	0.0	2.0	0.1	0.1	0.1	0.8	4.2	3.5	5.0	4.8	2.5	4.5	3.4	3.4	3.4	1.7
CDX1		ENSG00000113722	"Caudal type homeobox 1"	P47902	5	150166795-150184558	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"intestine: 83.7"	"Cell line enriched"	"Detected in some"	5	"BJ hTERT+: 11.9"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 125.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"thalamus: 0.3"	"Group enriched"	"Detected in some"	10	"midbrain: 1.0;pons and medulla: 1.2;thalamus: 2.1"	HPA055196	Enhanced									"HPA055196: AB_2682734"	"unprognostic (2.50e-3)"	"unprognostic (3.90e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.09e-2)"	"unprognostic (5.89e-2)"	"unprognostic (1.54e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.20e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.96e-1)"	"unprognostic (1.83e-7)"	"unprognostic (2.10e-1)"	"unprognostic (4.25e-1)"	"unprognostic (5.42e-3)"	"unprognostic (2.16e-3)"	0.2	0.1	0.1	18.6	0.2	0.0	0.2	0.1	0.2	0.2	63.6	0.2	0.1	19.2	0.2	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1	38.5	0.1	0.1	0.1	0.1	0.2	83.7	1.5	0.1	0.1	0.1	0.9	0.1	0.5	0.1	0.3	0.2	0.2	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.9	0.3	0.0	11.9	0.1	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1
MGAM	MGA	ENSG00000257335	Maltase-glucoamylase	O43451	7	141907813-142106747	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"intestine: 155.5"	"Cell line enhanced"	"Detected in some"		"A549: 3.6;BJ hTERT+: 3.2;HL-60: 5.3;U-937: 8.5;WM-115: 2.0"	"Cancer enriched"	"Detected in some"	7	"renal cancer: 4.9"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	8	"neutrophil: 14.1"	"Lineage enriched"	"Detected in single"	104	"granulocytes: 14.1"	"Region enriched"	"Detected in single"	12	"olfactory region: 3.1"					HPA002270	Enhanced					68000	68000			"HPA002270: AB_1079366"	"unprognostic (1.02e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.13e-1)"	"unprognostic (6.95e-3)"	"unprognostic (2.80e-1)"	"unprognostic (7.81e-2)"	"unprognostic (7.32e-3)"	"unprognostic (3.83e-2)"	"unprognostic (4.97e-1)"	"unprognostic (2.17e-2)"	"unprognostic (6.86e-2)"	"unprognostic (1.99e-1)"	"prognostic favourable (6.16e-5)"	"unprognostic (1.82e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.34e-3)"	"unprognostic (3.03e-1)"	0.9	0.2	0.3	0.8	0.2	6.9	0.3	0.2	0.2	0.2	59.4	0.1	7.6	25.2	0.2	36.0	0.2	1.0	0.1	0.3	0.2	0.2	8.7	0.4	2.1	0.1	0.3	0.1	0.2	0.2	0.0	0.2	0.1	0.1	0.6	0.0	0.1	0.2	3.2	0.2	0.1	155.5	0.1	0.3	8.3	0.7	4.3	0.1	0.1	0.2	0.1	0.1	0.2	0.2	0.0	0.0	14.1	0.1	0.0	0.0	0.0	0.0	3.6	0.2	0.1	0.0	0.0	0.4	0.1	3.2	0.3	0.2	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	1.4	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.3	0.0	0.4	0.1	0.0	0.0	0.0	0.3	1.0	0.4	0.1	0.3	0.0	0.1	0.0	8.5	2.0	0.0	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.1	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.2	0.2	0.2	0.2	0.3	0.1	0.1	0.1
MYO5B	KIAA1119	ENSG00000167306	"Myosin VB"	Q9ULV0	18	49822813-50195093	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"intestine: 92.2"	"Cell line enhanced"	"Detected in many"		"A-431: 20.6;HaCaT: 32.6;RH-30: 50.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"NK-cell: 2.4"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA040593, HPA040902, HPA069773"	Enhanced		Approved	"Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA040593: AB_10795525, HPA040902: AB_10796230, HPA069773: AB_2686194"	"unprognostic (2.51e-1)"	"unprognostic (2.15e-2)"	"unprognostic (2.12e-2)"	"unprognostic (6.17e-3)"	"unprognostic (2.14e-1)"	"unprognostic (8.84e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.59e-1)"	"unprognostic (4.13e-2)"	"unprognostic (3.46e-1)"	"prognostic unfavourable (2.26e-5)"	"unprognostic (4.48e-2)"	"prognostic favourable (1.45e-11)"	"unprognostic (2.17e-3)"	"unprognostic (1.50e-1)"	"unprognostic (6.56e-2)"	"unprognostic (3.28e-1)"	2.0	1.2	1.1	12.7	1.3	0.0	5.2	0.4	2.5	7.5	56.9	1.0	13.7	23.5	1.8	10.4	20.3	4.6	20.6	2.0	1.8	1.2	19.1	13.9	9.4	0.6	0.7	1.5	1.7	16.4	9.3	10.5	13.5	2.1	6.0	17.5	8.4	21.6	8.7	0.6	14.5	92.2	0.8	0.7	0.9	13.1	5.5	0.3	2.4	16.3	14.9	17.4	4.0	11.8	1.0	0.1	0.0	0.0	2.4	0.6	0.0	20.6	5.6	0.1	0.1	0.0	0.0	11.3	0.1	0.8	0.4	0.0	14.6	8.8	0.0	5.2	0.0	32.6	7.4	8.8	0.4	0.0	2.2	0.0	2.5	10.3	0.0	0.0	0.0	0.0	7.8	0.2	5.4	0.7	0.1	8.1	0.8	8.0	0.0	0.0	1.5	2.3	0.0	50.5	3.5	18.6	4.2	11.2	0.2	7.9	9.3	0.0	5.5	0.0	0.4	0.0	11.4	0.1	2.1	5.5	3.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.6	1.0	0.4	0.1	0.0	0.0	0.2	0.4	0.0	2.4	0.0	0.1	0.1	0.0	1.1	1.3	0.4	2.5	1.8	1.2	0.7	1.5	2.1	0.3
NLRP6	"CLR11.4, NALP6, PAN3, PYPAF5"	ENSG00000174885	"NLR family pyrin domain containing 6"	P59044	11	278365-285359	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"intestine: 63.8"	"Group enriched"	"Detected in some"	4	"REH: 4.3;U-266/70: 8.6"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"neutrophil: 14.6"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"HPA043681, HPA048500"	Supported									"HPA043681: AB_2678614, HPA048500: AB_2680422"	"unprognostic (6.37e-3)"	"unprognostic (4.69e-2)"	"unprognostic (4.26e-2)"	"unprognostic (3.42e-2)"	"unprognostic (6.40e-2)"	"unprognostic (1.18e-2)"	"prognostic favourable (4.23e-5)"	"unprognostic (8.82e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.66e-1)"	"unprognostic (5.16e-3)"	"unprognostic (2.19e-1)"	"unprognostic (3.11e-3)"	"unprognostic (4.96e-2)"	"unprognostic (2.14e-2)"	"unprognostic (6.90e-3)"	"unprognostic (3.69e-2)"	0.4	0.0	0.1	1.3	0.1	0.2	0.1	0.1	0.1	0.1	29.1	0.1	0.1	25.9	0.1	0.1	0.1	0.5	0.1	0.1	0.1	0.0	0.9	1.6	0.6	0.6	0.1	0.1	0.1	0.2	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	63.8	0.1	0.1	2.7	0.2	0.1	0.1	0.1	0.1	0.1	0.2	0.2	0.1	0.3	0.1	14.6	4.0	0.9	2.4	0.6	0.0	0.0	0.1	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.7	1.4	0.0	0.4	0.5	1.0	0.3	0.0	4.3	0.0	1.6	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.3	0.0	8.6	0.5	0.4	0.0	0.6	0.0	0.0	0.0	0.0	0.7	0.3	1.4	0.3	1.7	1.2	0.1	0.1	2.0	2.4	14.6	0.9	4.0	0.0	0.0	0.6	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
PRORY	CYorf17	ENSG00000183146	"Proline rich, Y-linked"	Q9H606	Y	21382954-21386360	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	4	"intestine: 5.4"	"Cell line enriched"	"Detected in some"	8	"U-266/84: 8.4"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"																																				"unprognostic (1.59e-1)"			0.0	0.0	0.0	0.1	0.1	1.0	0.0	0.0	0.4	0.0	2.0			0.1	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	1.6		0.0	0.0	0.1	0.4	5.4	0.0	0.0	0.1	0.0	0.7			0.0		0.0	0.0	0.0	0.9	0.3	1.2	0.4	0.3	0.9	0.2	0.2	0.0	0.1	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.3	0.1	0.0	0.1	0.0	0.2	0.0	0.4	0.0	0.2	0.1	0.2	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.2	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.2	0.5	0.1	0.5	0.6	0.0	0.2	0.4	0.9	0.0	0.9	8.4	0.2	0.2	0.7	0.1	0.6	0.2	0.5	0.7	0.4	0.5	0.4	0.4	0.7	0.2	0.9	0.7	0.9	1.2	0.3	0.4	0.3	0.0	0.2										
SLC10A2	"ASBT, ISBT"	ENSG00000125255	"Solute carrier family 10 member 2"	Q12908	13	103043998-103066846	"Disease related genes, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	4	"intestine: 40.9"	"Cell line enhanced"	"Detected in some"		"AF22: 1.1;HAP1: 2.4;NB-4: 1.2;U-2197: 1.1"	"Cancer enriched"	"Detected in single"	11	"renal cancer: 4.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA004795	Approved									"HPA004795: AB_1856953"											"unprognostic (2.82e-2)"		"prognostic favourable (5.78e-5)"	"unprognostic (1.64e-2)"	"unprognostic (1.29e-1)"			0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.5	0.0	0.0	13.6	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	9.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	40.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	2.4	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.1	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	1.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SMIM31	LINC01207	ENSG00000248771	"Small integral membrane protein 31"		4	164754064-164803795	"Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"			"Tissue enriched"	"Detected in some"	4	"intestine: 42.7"	"Cell line enhanced"	"Detected in some"		"A549: 3.2;RPTEC TERT1: 4.4"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 8.8"					"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"								"Secreted - unknown location"						"unprognostic (2.84e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.87e-4)"			"unprognostic (2.95e-2)"	"unprognostic (1.78e-1)"			"unprognostic (4.17e-2)"	"unprognostic (4.82e-1)"		"unprognostic (9.47e-2)"			"unprognostic (5.63e-3)"	0.0	0.0	0.1	4.0	0.0	0.2	0.6	0.0	0.0	3.1	25.4	0.0	0.0	13.7	0.7	0.2	0.1	0.0	6.9	0.0	0.0		0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	9.8	9.8	0.0	2.1	0.0	0.0	0.0	42.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.1	0.0	1.1	1.4	3.1	0.5	1.3	0.5	0.0	0.4	3.2	0.2	0.8	0.2	0.4	0.8	0.3	0.1	0.3	0.3	1.2	0.4	0.6	0.3	0.2	0.7	0.1	0.4	0.1	0.3	0.4	0.0	0.4	0.2	0.4	0.6	0.9	0.3	0.3	0.2	0.2	0.0	0.5	1.4	0.0	0.6	0.3	1.4	0.4	0.1	0.6	0.2	1.4	4.4	0.6	0.5	0.2	0.4	0.5	0.6	0.4	0.7	0.4	0.4	0.2	0.8	0.5	1.7	0.4	0.7	0.7	0.7	1.2	3.1	0.5	0.6	0.4	0.3	0.4	0.4	0.4	0.4	0.2	1.1	0.5	0.5	2.8	1.3	0.4	1.4	0.3	0.0										
TMEM92	FLJ33318	ENSG00000167105	"Transmembrane protein 92"	Q6UXU6	17	50271406-50281485	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"intestine: 74.7"	"Group enriched"	"Detected in some"	4	"A549: 9.7;CACO-2: 16.5;CAPAN-2: 15.9;EFO-21: 33.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	21	"neutrophil: 5.5"	"Lineage enriched"	"Detected in single"	21	"granulocytes: 5.5"					"Low region specificity"	"Detected in all"			"HPA063009, HPA069820"	Approved		Enhanced	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA063009: AB_2684921, HPA069820: AB_2686208"	"unprognostic (3.54e-3)"	"unprognostic (2.39e-2)"	"unprognostic (9.85e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.63e-1)"	"prognostic unfavourable (8.35e-4)"	"unprognostic (4.37e-3)"	"unprognostic (2.45e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.39e-1)"	"unprognostic (3.88e-3)"	"unprognostic (2.97e-2)"	"prognostic unfavourable (1.14e-6)"	"unprognostic (3.44e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.73e-1)"	"unprognostic (7.81e-2)"	0.2	0.1	0.3	1.9	0.3	0.4	0.3	0.3	0.3	3.3	27.9	0.3	0.1	23.3	1.2	0.3	1.0	0.7	11.7	0.1	0.8	0.3	0.4	10.2	6.1	0.1	0.3	0.2	2.4	1.2	0.0	0.1	0.3	0.9	1.2	1.8	1.1	4.3	1.2	0.1	0.2	74.7	0.4	0.4	0.3	17.9	0.5	0.3	0.1	0.1	0.4	1.6	2.2	3.7	0.1	0.2	5.5	0.1	0.0	0.0	0.0	1.0	9.7	0.2	0.0	0.0	0.4	2.1	0.2	0.3	0.0	0.0	16.5	15.9	0.0	33.0	0.7	0.1	0.2	1.8	0.1	2.6	0.1	0.0	1.0	1.6	0.1	0.1	0.1	0.1	1.9	0.1	0.5	0.0	1.5	0.0	0.0	0.0	0.0	0.2	3.6	4.3	0.2	0.0	4.1	3.6	0.0	0.0	0.0	0.0	0.1	0.0	2.0	0.5	0.0	0.1	2.3	0.0	0.0	0.0	0.2	0.1	0.2	1.7	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	5.5	0.0	0.0	0.1	0.0	0.0	0.3	0.3	0.3	0.3	0.8	0.3	0.3	0.2	0.9	0.3
TSPAN8	"CO-029, TM4SF3"	ENSG00000127324	"Tetraspanin 8"	P19075	12	71125085-71441898	"Cancer-related genes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"intestine: 235.3"	"Cell line enhanced"	"Detected in some"		"CACO-2: 14.9;HeLa: 18.0;PC-3: 57.3;RPTEC TERT1: 11.0;RT4: 13.2"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 283.9"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"							"CAB026009, HPA044337"	Enhanced		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"CAB026009: , HPA044337: AB_2678899"	"unprognostic (1.64e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.64e-1)"	"unprognostic (6.40e-2)"	"unprognostic (6.81e-2)"	"unprognostic (7.29e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.15e-1)"	"unprognostic (5.62e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.01e-3)"	"unprognostic (2.93e-1)"	"prognostic unfavourable (9.66e-5)"	"unprognostic (1.88e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.97e-2)"	"prognostic favourable (7.36e-5)"	1.9	0.8	0.7	24.1	2.3	0.0	1.1	0.6	1.3	2.0	139.5	2.8	1.5	83.2	1.2	1.5	1.1	1.3	30.8	1.0	0.7	0.7	7.6	3.7	5.1	1.0	4.7	1.0	6.9	9.9	0.0	0.8	0.7	3.5	14.2	79.5	2.6	11.7	1.0	12.5	2.4	235.3	3.4	9.7	0.6	55.5	1.6	2.7	0.6	1.8	3.1	5.0	3.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.7	0.2	0.9	0.0	0.0	0.0	0.0	14.9	1.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	18.0	1.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	4.0	0.0	0.0	0.1	0.0	0.0	1.0	0.1	57.3	0.0	0.0	1.5	11.0	13.2	1.3	2.7	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.1	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	2.3	0.6	1.3	0.7	0.7	4.7	1.0	3.5	2.7
